Regulatory announcement (RNS) · 3rd Quarter Results

3rd Quarter Results

Barclays plc · published 22 October 2026 06:00 UTC · Barclays Bank UK credit rating and record

RNS Number : 9495Z

Barclays PLC

22 October 2026

Barclays PLC

Q326 Results Announcement

September 2026

Notes

The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the nine months ended 30

September 2026 to the corresponding nine months of 2025 and balance sheet analysis as at 30

September 2026 with comparatives relating to 31 December 2025 and 30

September 2025. The abbreviations ‘£m’ and ‘£bn’ represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations ‘$m’ and ‘$bn’ represent millions and thousands of millions of US Dollars respectively; and the abbreviations ‘€m’ and ‘€bn’ represent millions and thousands of millions of Euros respectively.

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary, which can be accessed at

home.barclays/investor-relations

The information in this announcement, which was approved by the Board of Directors on 21

October 2026, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31

December 2025, which contain an unmodified audit report under Section 495 of the Companies Act 2006 (which does not make any statements under Section 498 of the Companies Act 2006) have been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.

These results will be furnished on Form 6-K to the US Securities and Exchange Commission (SEC) as soon as practicable following publication of this document. Once furnished to the SEC, a copy of the Form 6-K will be available from the SEC’s website at www.sec.gov.

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal roadshows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group

Non-IFRS performance measures

Barclays’ management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays’ management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 70 to 79 for definitions and calculations of non-IFRS performance measures included throughout this document, and reconciliations to the most directly comparable IFRS measures.

Forward-looking statements

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group’s future financial position, business strategy, income levels, costs, assets and liabilities, impairment charges, provisions, capital leverage and other regulatory ratios, capital distributions (including policy on dividends and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including sustainability-related commitments and targets), plans and objectives for future operations, International Financial Reporting Standards (“IFRS”) and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulations, governmental and regulatory policies, expectations and actions, voluntary codes of practices and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing sustainability reporting standards (including emissions accounting methodologies); changes in tax laws and practice; the outcome of current and future legal proceedings and regulatory investigations; the Group’s ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively or navigate inconsistencies and conflicts in the manner in which climate policy is implemented in the regions where the Group operates, including as a result of the adoption of rules and regulations taking a different or opposing position on sustainability matters, or other forms of governmental and regulatory action against sustainability policies; environmental, social and geopolitical risks and incidents and similar events beyond the Group’s control; financial crime; the impact of competition in the banking and financial services industry; capital, liquidity, leverage and other regulatory rules and requirements applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; reforms to benchmark interest rates and indices; higher or lower asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; changes in trade policy, including the imposition of tariffs or other protectionist measures; the direct and indirect consequences of the conflicts in the Middle East and Ukraine on European and global macroeconomic conditions, political stability and financial markets; changes in US legislation and policy; developments in the UK’s relationship with the European Union; the risk of cyberattacks, information or security breaches, technology failures or operational disruptions and any subsequent impact on the Group’s reputation, business or operations; the use of new technology, including artificial intelligence; the Group’s ability to access funding; and the success of acquisitions, disposals, joint ventures and other strategic transactions. A number of these factors are beyond the Group’s control. As a result, the Group’s actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group’s forward-looking statements. In setting its targets and outlook for the period 2026-2028, Barclays has made certain assumptions about the macroeconomic environment, including, without limitation, inflation, interest and unemployment rates, the different markets and competitive conditions in which Barclays operates, and its ability to grow certain businesses and achieve costs savings and other structural actions. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in Barclays PLC’s filings with the US Securities and Exchange Commission (“SEC”) (including, without limitation, Barclays PLC’s Annual Report on Form 20-F for the financial year ended 31 December 2025), which are available on the SEC’s website at www.sec.gov.

Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Performance Highlights

Barclays delivered a return on tangible equity (RoTE) of 11.7% in Q326, announced a £500m share buyback, and is on track to deliver its 2026 and 2028 targets

C. S. Venkatakrishnan, Group Chief Executive, commented

“I am pleased with the ongoing momentum of Barclays' operational and financial performance, with RoTE of 11.7% in Q326 and 13.8% year-to-date. Income of £7.4bn is up 3% from the same quarter last year. Our cost: income ratio has improved to 62% from 63%, profit before tax grew by 12% to £2.3bn, and our earnings per share (EPS) has increased 18%. With one quarter to go before the end of our original three-year plan, we have either achieved or are on track to achieve all of our 2026 Group targets. We are confident in and committed to the 2028 targets that we laid out earlier in the year. In Q326 we drove 7% year-on-year loan growth

in our highest returning UK businesses

, with particular strength in UK Corporate Bank, up 14% year-on-year. The Investment Bank delivered strong Equities performance, offsetting a challenging environment for FICC.

Our strong organic capital generation and common equity tier 1 (CET1) ratio of 14.2% means that we are in a position to announce a new £500m share buyback tranche today, bringing year-to-date distributions to £2.8bn, up 46% year-on-year.”



Q326 Group RoTE of 11.7% (Q325: 10.6%)

and Q326 YTD Group RoTE of 13.8% (Q325 YTD: 12.3%), on track to deliver greater than 12% in 2026



Q326 EPS of 12.3p

, up 18% year-on-year and 43.0p in Q326 YTD, up 23% year-on-year



UK loan growth of 7% year-on-year

with UK Corporate Bank up 14%

£28bn of the planned c.£30bn UK risk weighted assets (RWAs) growth delivered since 2024

, of which £3bn was delivered in Q326



Strong performance in Equities, with Q326 up 47% year-on-year

, reflecting prior investment in Prime Financing and Equity Derivatives offset by a challenging environment for FICC (19% reduction year-on-year)



Continued operational progress in US Consumer Bank

reflecting growth across partnership cards, retail deposits, and originated loan balances through Best Egg



Structurally reducing the cost base through expected technology-enabled FTE reductions

, creating capacity for further investment in the business

Q326 structural cost actions (SCAs) of £201m (Q325: £93m), with a further c.£300m planned in Q426

Group total costs expected to be c.£18.5bn in FY26 and c.£18.4bn in FY27



Strong capital position and increased shareholder distributions

CET1 ratio of 14.2% and announced intention to initiate a share buyback of up to £500m (Q325: £500m), bringing YTD announced distributions to £2.8bn, up 46% year-on-year



Greater capital flexibility following reduction in Pillar 2A requirements, alongside Basel 3.1 implementation

RWAs expected to increase by £8-15bn on 1 January 2027, equivalent to a reduction in the CET1 ratio of 30-55bps

Expect 59bps reduction in the Pillar 2A requirement, lowering the MDA

requirement from 12.2% to 11.6%

Key financial metrics:

RoTE

EPS

Cost: income ratio

LLR

Income

Profit before tax

Attributable profit

TNAV per share

CET1 ratio

Total capital return

Q326

11.7%

12.3p

62%

43bps

£7.4bn

£2.3bn

£1.6bn

410p

14.2%

£2.8bn

Q326 YTD

13.8%

43.0p

57%

55bps

£23.9bn

£8.4bn

£5.8bn

Q326 Group Performance Highlights:



Group RoTE increased to 11.7% (Q325: 10.6%), with profit before tax of £2.3bn (Q325: £2.1bn)



Group income of £7.4bn increased 3% year-on-year

Group net interest income (NII) excluding Barclays Investment Bank and Head Office was £3.5bn, up 7% year-on-year, driven by higher structural hedge income and continued lending momentum

Year-on-year NII growth across all operating divisions



Group cost: income ratio of 62% (Q325: 63%), with total operating expenses of £4.6bn, increased 1% year-on-year

Group operating costs increased to £4.6bn (Q325: £4.3bn), reflecting business growth (including £65m related to changes in material risk taker (MRT) compensation mix), inflation and further investment spend (including £201m of Q326 SCAs, with £110m in Barclays UK), partially offset by c.£200m of cost efficiency savings



Credit impairment charges were £0.5bn, down 20% year-on-year,

reflecting more normalised charges in the Investment Bank and US Consumer Bank.

The loan loss rate (LLR) was 43bps (Q325: 57bps)

UK loan growth comprises aggregate growth in loans and advances to customers across Barclays UK, UKCB and PBWM.

Represents RWAs from business growth in Barclays UK, UKCB and PBWM since January 2024, excluding the effects of securitisations, model updates and other methodological changes. Also excludes additional operational risk RWAs related to organic growth.

At H126 guided SCAs would be up to £0.5bn for H226, which is c.£0.3bn higher than usual annual SCA run-rate.

Maximum distributable amount.

Q326 YTD total capital return: includes the £500m buyback announced at Q126 Results, the £1.0bn buyback and c.£0.8bn dividend announced at H126 Results and the £500m buyback announced at Q326 Results.

Q326 Business Performance Highlights



Barclays UK RoTE was broadly stable at 21.2% (Q325: 21.8%)

as income increased 4%, driven by higher structural hedge income supported by stable deposits deposit, offset by costs increasing 6% driven by £110m SCAs taken in Q326



Barclays UK Corporate Bank (UKCB) RoTE increased to 23.5% (Q325: 22.8%)

as income increased 10%, reflecting higher structural hedge income and higher average deposit and lending balances, partially offset by a cost increase of 10%, given the non-repeat of Q325 UK regulatory levies credit



Barclays Private Bank and Wealth Management (PBWM) RoTE decreased to 23.8% (Q325: 26.4%).

Income growth was 10%, reflecting 6% higher client asset and liabilities balances year-on-year. Costs increased 18% reflecting ongoing investments in the wealth proposition



Barclays Investment Bank (IB) RoTE decreased to 9.5% (Q325: 10.1%).

Income growth was 1% and lower impairment charge were more than offset by a 4% increase in costs including £57m Q326 SCAs and £55m MRT compensation mix, and higher average allocated tangible equity



Barclays US Consumer Bank (USCB) RoTE decreased to 10.9% (Q325: 13.5%)

reflecting broadly stable income and 14% higher costs reflecting the Best Egg acquisition (Q326 first full quarter of Best Egg costs)

Group financial targets and guidance

2026



Returns

: Group RoTE of greater than 12%



Capital returns

plan to return at least £10bn of capital to shareholders between 2024 and 2026, through dividends and share buybacks, with a continued preference for buybacks

Progressive increase in total capital returns versus 2025

Share buybacks announced quarterly

Dividends to be paid semi-annually, including planned £2bn dividend for 2026



Income:

Group total income of c.£31.5bn

Group NII excluding IB and Head Office greater than £13.7bn and Barclays UK NII around the middle of the £8.1bn - £8.3bn guided range



Costs:

Group cost: income ratio of high 50s in percentage terms and total costs of c.£18.5bn

Run-rate costs in 2026 of c.£18.0bn which exclude additional SCAs of c.£0.3bn above normal annual run-rate, c.£0.1bn MRT compensation mix adjustments and c.£0.1bn Motor Finance provision booked in Q126



Impairment

: expect Group LLR to be around the top of the 50-60bps through the cycle range



Capital

: CET1 ratio target range of 13-14%

IB RWAs mid 50s% of Group RWAs

Impact of regulatory change on RWAs in line with our prior guidance of c.£19-26bn

c.£8-15bn RWAs from Basel 3.1, with implementation expected from 1 January 2027

Expect Pillar 2A CET1 requirement to reduce by 59bps upon implementation, reducing MDA to 11.6%

c.£11bn RWAs from USCB moving to an Internal Ratings Based (IRB) model, subject to portfolio changes and regulatory approval, expected in H2 2027

Expect minimal change in Pillar 2A requirement upon model implementation

2027



Costs

: Group costs of c.£18.4bn and Barclays UK cost: income ratio of high 40s%

2028



Returns

: Group RoTE of greater than 14%



Capital returns

plan to return greater than £15bn of capital to shareholders between 2026 and 2028, through dividends and share buybacks. This provides capacity for additional investment and growth, exceeding the level of investment in the current plan



Income:

greater than 5% compound annual growth rate (CAGR) 2025-2028



Costs:

Group cost: income ratio of low 50s in percentage terms. Cost target includes total gross efficiency savings of greater than £2bn in 2026-2028



Impairment

: expect Group LLR of 50-60bps through the cycle



Capital

: CET1 ratio target range of 13-14%

IB RWAs of c.50% of Group RWAs

Targets and guidance are based on management's current expectations as to the macroeconomic environment and the business and may be subject to change.

This multi-year plan is subject to supervisory and Board approvals, anticipated financial performance and our published CET1 ratio target range of 13-14%.

Fundamental review of the trading book (FRTB) impact mostly expected in 2027.

Barclays Group results

Nine months ended

Three months ended

30.09.26

30.09.25

30.09.26

30.09.25

£m

% Change

£m

% Change

Barclays UK

6,866

6,446

2,349

2,253

Barclays UK Corporate Bank

1,661

1,525

573

522

Barclays Private Bank and Wealth Management

1,082

1,032

369

335

Barclays Investment Bank

11,115

10,263

3,129

3,083

Barclays US Consumer Bank

3,047

2,628

928

941

(1)

Head Office

169

(44)

(48)

Total income

23,866

22,063

7,365

7,167

Operating costs

(13,438)

(12,661)

(6)

(4,565)

(4,254)

(7)

UK regulatory levies

(95)

(84)

(13)

(11)

Litigation and conduct

(92)

(342)

(255)

Total operating expenses

(13,625)

(13,087)

(4)

(4,560)

(4,497)

(1)

Other net income

(8)

(49)

Profit before impairment

10,285

9,024

2,825

2,709

Credit impairment charges

(1,897)

(1,744)

(9)

(503)

(632)

Profit before tax

8,388

7,280

2,322

2,077

Tax charge

(1,791)

(1,538)

(16)

(422)

(365)

(16)

Profit after tax

6,597

5,742

1,900

1,712

Non-controlling interests

(19)

(23)

—

Other equity instrument holders

(741)

(739)

—

(254)

(255)

—

Attributable profit

5,837

4,980

1,646

1,457

Performance measures

Return on average tangible shareholders' equity

13.8%

12.3%

11.7%

10.6%

Average tangible shareholders' equity (£bn)

56.6

54.0

56.4

55.1

Cost: income ratio

57%

59%

62%

63%

Loan loss rate (bps)

Basic earnings per ordinary share

43.0p

35.1p

12.3p

10.4p

Dividend per ordinary share

5.9p

3.0p

Share buybacks announced (£m)

2,000

1,500

500

—

Total payout equivalent per share

c.20.7

c.13.6p

Basic weighted average number of shares (m)

13,571

14,189

(4)

13,426

14,045

(4)

Period end number of shares (m)

13,379

13,996

(4)

Period end tangible shareholders' equity (£bn)

54.8

54.9

Balance sheet and capital management

As at 30.09.26

As at 31.12.25

As at 30.09.25

£bn

Gross loans and advances at amortised cost

459.8

441.3

437.5

Loans and advances at amortised cost

454.5

430.0

426.5

Loans and advances at amortised cost impairment coverage ratio

1.2%

Total assets

1,737.6

1,544.2

1,629.2

Deposits at amortised cost

599.3

585.6

575.3

Tangible net asset value per share

410p

409p

392p

Common equity tier 1 ratio

14.2%

14.3%

14.1%

Common equity tier 1 capital

52.4

51.1

50.3

Risk weighted assets

369.8

356.8

357.4

UK leverage ratio

4.9%

5.1%

4.9%

UK leverage exposure

1,344.0

1,247.3

1,285.3

Funding and liquidity

Group liquidity pool (£bn)

372.2

337.8

332.9

Liquidity coverage ratio

157.0%

170.0%

174.6%

Net stable funding ratio

135.8%

135.2%

135.3%

Loan: deposit ratio

76%

73%

74%

Customer loan: deposit ratio

64%

62%

Refer to pages

for further information on how capital, RWAs and leverage are calculated.

Gross loans and advances at amortised cost comprises: loans and advances to customers and banks at amortised cost, debt securities, and portfolios reclassified as held for sale, gross of impairment allowance, and is the denominator used in the LLR metric.

From Q326, the customer loan to deposit ratio has been introduced, calculated as loans and advances to customers at amortised cost divided by customer deposits at amortised cost, to improve comparability with peers.

Group Finance Director’s Review

Q326 YTD Group performance



Barclays delivered a profit before tax of £8,388m (Q325 YTD: £7,280m), RoTE of 13.8% (Q325 YTD: 12.3%) and EPS of 43.0p (Q325 YTD: 35.1p)



The Group has a diverse income profile across businesses and geographies.

The 2% year-on-year appreciation of average GBP against USD negatively impacted income and profits, and positively impacted credit impairment charges and total operating expenses



Group income increased 8% to £23,866m,

as continued structural hedge momentum, higher income in Global Markets and Investment Banking fees and the c.£225m gain from the sale of the American Airlines portfolio (AA portfolio), were partially offset by retail deposits dynamics and net losses on fair value lending and cost of hedging in the IB



Group total operating expenses increased to £13,625m (Q325 YTD: £13,087m)

Group operating costs increased 6% to £13,438m, reflecting business growth (including higher performance costs reflecting higher income), inflation, and further investment spend (including the Best Egg acquisition and higher SCAs), partially offset by c.£550m of cost efficiency savings and foreign exchange movements

Litigation and conduct charges of £92m (Q325 YTD: £342m) primarily reflected a £105m increase in the provision for the UK Financial Conduct Authority (FCA) motor finance redress scheme in Q126. Q325 YTD included a £235m charge for motor finance redress



Credit impairment charges increased to £1,897m (Q325 YTD: £1,744m),

primarily driven by higher single name charges year-on-year in IB. Total coverage ratio remained stable at 1.2% (December 2025: 1.2%)



The effective tax rate (ETR) was 21.4% (Q325 YTD: 21.1%)



Attributable profit was £5,837m (Q325 YTD: £4,980m)



Total assets increased to £1,737.6bn (December 2025: £1,544.2bn)

driven by higher trading activity in Global Markets, higher lending across the Group, and growth in the liquidity pool



Tangible net asset value (TNAV) per share was broadly stable at 410p (December 2025: 409p)

as EPS of 43.0p was partially offset by a 24p reduction from the cash flow hedge reserve and a 15p net reduction from the impact of share buybacks and dividends paid during Q326 YTD

Group capital and leverage



The CET1 ratio remained broadly stable at 14.2% (December 2025: 14.3%). Taking into account the impact of the £500m share buyback announced today, the CET1 ratio as of 30 September 2026 would be reduced to 14.0%



Excluding the marginal increase in the CET1 ratio from the Q226 USCB sale of the AA portfolio and acquisition of Best Egg, other significant movements were:

150bps increase from attributable profit

108bps decrease driven by shareholder distributions including the now completed £1.5bn total share buybacks announced with FY25 and Q126 results, the ongoing £1.0bn share buyback announced with Q226 results, and the accrual for the FY26 dividend

58bps decrease due to a £14.9bn increase in RWAs, excluding the impact of foreign exchange movements, primarily driven by lending growth in UK businesses and higher activity in IB

A £0.2bn increase in CET1 capital due to an increase in the currency translation reserve was offset by a £1.3bn increase in RWAs as a result of foreign exchange movements



The UK leverage ratio decreased to 4.9% (December 2025: 5.1%) primarily driven by a £96.7bn increase in leverage exposure to £1,344.0bn (December 2025: £1,247.3bn), partially offset by a £1.8bn increase in Tier 1 capital. The increase in leverage exposure was driven by higher trading activity in Global Markets and increased lending across the Group

Group funding and liquidity



The liquidity metrics remain above regulatory requirements, underpinned by well-diversified sources of funding, a stable global deposit franchise and a highly liquid balance sheet



The liquidity pool was £372.2bn, an increase of £34.3bn from December 2025. The increase in the liquidity pool was driven by deposit growth across businesses and increased wholesale funding



The average

liquidity coverage ratio (LCR) was 157.0% (December 2025: 170.0%), equivalent to a surplus of £118.4bn (December 2025: £131.2bn)



Total deposits increased to £599.3bn (December 2025: £585.6bn), primarily driven by growth in the International Corporate Bank (ICB)



The average

Net Stable Funding Ratio (NSFR) was 135.8% (December 2025: 135.2%), which represents a £173.5bn surplus (December 2025: £166.3bn) above the 100% regulatory requirement



Wholesale funding outstanding, excluding repurchase agreements, was £229.5bn (December 2025: £220.1bn)



The Group issued £9.9bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company), completing the targeted 2026 MREL issuance plan within H126. The Group has a strong MREL position with a ratio of 35.2%, which is in excess of the regulatory requirement of 30.5% excluding any applicable confidential institution specific Prudential Regulation Authority (PRA) buffer. The Group remains above its minimum capital regulatory requirements and applicable buffers

Represents average of the last 12 spot month end ratios.

Represents average of the last four spot quarter end ratios.

Other matters



Motor finance commission arrangements:

In Q126, the FCA published its final rules for an industry-wide redress scheme for eligible motor finance customers where a commission was payable by the lender to the broker. Barclays holds a Motor Finance provision of £430m as at Q326 (H126: £430m). In Q326, the Upper Tribunal ordered a suspension of parts of the redress scheme following four legal challenges to the FCA’s final rules. The legal challenges are to be heard by the Upper Tribunal in Q127. These challenges will delay and may otherwise affect the implementation of the redress scheme although the FCA has indicated a willingness to consider how, despite such challenges, firms may be able to pay redress in line with its proposed scheme to certain cohorts of eligible customers in advance of the Upper Tribunal hearing. Barclays is considering this option, which would be within the scope of its existing provision estimate. Given the legal challenges, the legal and regulatory outcomes and the nature, extent and timing of any remediation action, remain uncertain



USCB changes in Q226:

American Airlines co-branded credit card portfolio exit

: On 24 April 2026 Barclays exited its American Airlines co-branded credit card partnership, releasing £3.6bn of RWAs and generating a gain on sale of c.£225m

Best Egg acquisition:

On 1 May 2026, Barclays completed the acquisition of Best Egg for c.£0.6bn

, comprising

c.£0.5bn goodwill and intangibles, and c.£0.1bn of net financial assets. Best Egg is a leading US direct-to-consumer personal loan origination platform focused on prime borrowers



GoHenry acquisition:

On 1 October 2026, Barclays Bank UK PLC completed the acquisition of GoHenry, a money management platform for children and young people in the UK. The transaction is expected to marginally reduce the Group's CET1 ratio



One Churchill Place:

On 30 June 2026 Barclays announced it had acquired a 999-year leasehold interest in its global headquarters at One Churchill Place, London. The transaction secures Barclays’ control in its global headquarters, while providing greater certainty over long-term occupancy costs. The transaction values the acquired leasehold interest at £750m and is broadly neutral to the Group’s CET1 ratio and earnings

Anna Cross, Group Finance Director

Subject to customary post-completion purchase price adjustments.

Results by Business

Barclays UK

Nine months

ended

Three months ended

30.09.26

30.09.25

30.09.26

30.09.25

Income statement information

£m

% Change

£m

% Change

Net interest income

6,059

5,638

2,073

1,961

Net fee, commission and other income

807

808

—

276

292

(5)

Total income

6,866

6,446

2,349

2,253

Operating costs

(3,642)

(3,472)

(5)

(1,274)

(1,189)

(7)

UK regulatory levies

(49)

(44)

(11)

(5)

(1)

Litigation and conduct

(37)

(8)

Total operating expenses

(3,683)

(3,553)

(4)

(1,271)

(1,198)

(6)

Other net income

—

Profit before impairment

3,183

2,893

1,078

1,055

Credit impairment charges

(461)

(339)

(36)

(123)

(102)

(21)

Profit before tax

2,722

2,554

955

953

—

Attributable profit

1,880

1,737

666

647

Performance measures

Return on average allocated tangible equity

20.4%

19.6%

21.2%

21.8%

Average allocated tangible equity (£bn)

12.3

11.8

12.6

11.9

Cost: income ratio

54%

55%

54%

53%

Loan loss rate (bps)

Net interest margin

3.70%

3.59%

3.69%

3.68%

As at 30.09.26

As at 31.12.25

As at 30.09.25

Balance sheet information

£bn

Gross loans and advances at amortised cost

243.3

231.9

230.9

Loans and advances to customers at amortised cost

225.3

216.5

213.4

Total assets

306.6

299.6

300.2

Customer deposits at amortised cost

246.1

244.6

241.5

Loan: deposit ratio

98%

94%

95%

Customer loan: deposit ratio

92%

89%

88%

Risk weighted assets

90.6

85.8

86.7

Period end allocated tangible equity

12.6

11.8

11.9

Analysis of Barclays UK

Nine months ended

Three months ended

30.09.26

30.09.25

30.09.26

30.09.25

Analysis of total income

£m

% Change

£m

% Change

Retail Banking

5,221

4,880

1,785

1,708

Business Banking

1,645

1,566

564

545

Total income

6,866

6,446

2,349

2,253

Analysis of credit impairment (charges)/releases

Retail Banking

(479)

(302)

(59)

(135)

(98)

(38)

Business Banking

(37)

(4)

Total credit impairment charges

(461)

(339)

(36)

(123)

(102)

(21)

As at 30.09.26

As at 31.12.25

As at 30.09.25

Analysis of loans and advances to customers at amortised cost

£bn

Retail Banking

207.7

198.6

195.2

Business Banking

17.6

17.9

18.2

Total loans and advances to customers at amortised cost

225.3

216.5

213.4

Analysis of customer deposits at amortised cost

Retail Banking

195.2

192.7

189.3

Business Banking

50.9

51.9

52.2

Total customer deposits at amortised cost

246.1

244.6

241.5

Barclays UK

UK retail banking division, trusted by over 20 million customers. Includes Business Banking, serving small-to-medium sized enterprises (SMEs) with less than £6.5m in annual revenue. Key business updates include:



Completed the acquisition of GoHenry on 1 October 2026, extending our ability to support children, young people and families through money management and financial education services



Launched the new Barclays Mobile Banking app in Q326, providing a more personalised digital banking experience and supporting customers across a broad range of banking needs

Barclays UK delivered a RoTE of 20.4% (Q325 YTD: 19.6%)

supported by stability of deposits delivering robust income, and underpinned by strong asset quality.

Income statement - Q326 YTD compared to Q325 YTD



Profit before tax increased 7% to £2,722m



Total income increased 7% to £6,866m.

NII increased 7% to £6,059m, as higher structural hedge income and lending growth was partially offset by retail deposit dynamics and mortgage margin compression. Net fee, commission and other income remained stable at £807m



Total operating expenses increased 4% to £3,683m,

driven by £158m SCAs taken year-to-date and inflation. Ongoing efficiency savings continue to be reinvested, to drive sustainable improvement to the cost: income ratio



Credit impairment charges were £461m (Q325 YTD: £339m),

reflecting stable underlying credit performance. Total charges are higher than those in Q325 YTD, which benefitted from a recalibration adjustment in the Retail credit cards portfolio to reflect resilient customer behaviour. Retail credit cards 30 and 90 day arrears rates were 0.9% (Q325: 0.7%) and 0.3% (Q325: 0.2%) respectively. The Retail credit cards total coverage ratio was 4.3% (December 2025: 4.3%)

Balance sheet - 30 September 2026 compared to 31 December 2025



Loans and advances to customers at amortised cost increased £8.8bn to £225.3bn

, primarily driven by

growth in mortgages, partially offset by the impact of securitisations



Customer deposits at amortised cost increased

by £1.5bn to £246.1bn,

driven by an increase in Retail Banking deposits. The customer loan: deposit ratio

increased to 92% (December 2025: 89%)



RWAs increased to £90.6bn (December 2025: £85.8bn),

primarily due to growth in mortgages, partially offset by the securitisation of credit risk assets

Barclays UK Corporate Bank

Nine months ended

Three months ended

30.09.26

30.09.25

30.09.26

30.09.25

Income statement information

£m

% Change

£m

% Change

Net interest income

1,244

1,084

437

383

Net fee, commission and other income

417

441

(5)

136

139

(2)

Total income

1,661

1,525

573

522

Operating costs

(744)

(717)

(4)

(256)

(243)

(5)

UK regulatory levies

(17)

(15)

(13)

(2)

Litigation and conduct

—

(39)

—

Total operating expenses

(761)

(771)

(258)

(234)

(10)

Other net income

—

Profit before impairment

900

754

315

288

Credit impairment charges

(21)

(36)

(2)

(5)

Profit before tax

879

718

313

283

Attributable profit

606

480

218

196

Performance measures

Return on average allocated tangible equity

21.6%

18.8%

23.5%

22.8%

Average allocated tangible equity (£bn)

3.7

3.4

3.7

3.4

Cost: income ratio

46%

51%

45%

Loan loss rate (bps)

As at 30.09.26

As at 31.12.25

As at 30.09.25

Balance sheet information

£bn

Gross loans and advances at amortised cost

33.2

30.2

29.2

Loans and advances to customers at amortised cost

33.0

30.0

29.0

Deposits at amortised cost

87.2

88.7

86.7

Customer loan: deposit ratio

38%

34%

33%

Risk weighted assets

27.5

26.5

25.2

Period end allocated tangible equity

3.8

3.7

3.4

Nine months ended

Three months ended

30.09.26

30.09.25

30.09.26

30.09.25

Analysis of total income

£m

% Change

£m

% Change

Corporate lending

276

260

Transaction banking

1,385

1,265

482

432

Total income

1,661

1,525

573

522

Barclays UK Corporate Bank

UKCB offers corporate lending and transaction banking services to clients with annual revenue greater than £6.5m through to FTSE 350 companies. Trusted banking partner to approximately 13,000 clients

with an average client relationship of 19 years

. Key business updates include:



Completed the roll out of iPortal to all clients, providing easier access to Barclays' banking services through a single digital platform. Adoption reached c.45%, and is expected to reach 100% by year-end, supporting broader use of Barclays' lending, transaction banking and risk management services

UKCB delivered a RoTE of 21.6% (Q325 YTD: 18.8%)

, reflecting increased income from higher average deposit and lending balances, and positive operating jaws.

Income statement - Q326 YTD compared to Q325 YTD



Profit before tax increased 22% to £879m



Total income increased 9% to £1,661m,

NII increased 15% to £1,244m, driven by structural hedge income benefit, and higher average deposit and lending bala

nces.

Net fee, commission and other income decreased 5% to £417m, driven by lower liquidity pool income



Total operating expenses decreased 1% to £761m,

reflecting the non-repeat of prior year litigation and conduct charges, partially offset by higher investment spend to support business growth and efficiency strategy, with ongoing efficiency savings offsetting inflationary headwinds



Credit impairment charges were £21m (Q325 YTD: £36m)

, reflecting stable underlying credit performance

Balance sheet - 30 September 2026 compared to 31 December 2025



Loans and advances to customers at amortised cost increased to £33.0bn (December 2025: £30.0bn),

reflecting continued execution of our lending growth strategy



Deposits at amortised cost decreased to £87.2bn (December 2025: £88.7bn),

largely reflecting corporate liquidity environment



RWAs increased to £27.5bn (December 2025: £26.5bn),

reflecting higher client lending limits and growth in lending balances

As at 31st August 2026

Barclays Private Bank and Wealth Management

Nine months

ended

Three months ended

30.09.26

30.09.25

30.09.26

30.09.25

Income statement information

£m

% Change

£m

% Change

Net interest income

643

597

223

190

Net fee, commission and other income

439

435

146

145

Total income

1,082

1,032

369

335

Operating costs

(810)

(715)

(13)

(289)

(243)

(19)

UK regulatory levies

(4)

(3)

(33)

(1)

Litigation and conduct

Total operating expenses

(810)

(717)

(13)

(286)

(243)

(18)

Other net income

—

Profit before impairment

272

315

(14)

(10)

Credit impairment (charges)/ releases

(8)

(5)

(1)

Profit before tax

264

325

(19)

(14)

Attributable profit

216

256

(16)

(6)

Performance measures

Return on average allocated tangible equity

25.4%

30.9%

23.8%

26.4%

Average allocated tangible equity (£bn)

1.1

Cost: income ratio

75%

69%

78%

73%

Loan loss rate (bps)

(9)

Key facts

£bn

Net new assets under management

2.5

2.6

0.6

0.7

As at 30.09.26

As at 31.12.25

As at 30.09.25

Balance sheet information

£bn

Gross loans and advances at amortised cost

16.4

15.1

15.2

Loans and advances to customers at amortised cost

16.1

14.7

14.9

Deposits at amortised cost

74.4

72.0

70.6

Risk weighted assets

8.1

8.0

7.9

Period end allocated tangible equity

1.1

Invested assets

143.2

140.6

135.7

Of which:

Assets under management

56.5

52.9

51.3

Assets under supervision

86.7

87.7

84.4

Client assets and liabilities

234.0

227.6

221.5

Refer to page 47 for further information on net new assets under management, assets under management and assets under supervision.

Invested assets (held off-balance sheet) represent assets under management and supervision. Uninvested cash held under an investment mandate and reported within deposits is excluded from invested assets.

Client assets and liabilities refers to deposits, lending and invested assets.

Barclays Private Bank and Wealth Management

Serving clients across the UK wealth continuum and internationally in the wealth corridors between the UK, Europe, Middle East and Asia through an established brand with a full private bank offering. Key business updates include:



Launched booking centre in Singapore in Q326, combining local booking capabilities with access to Barclays’ global offering across private banking, lending, investments and wealth planning



Launched Planning and Advice service and removed Direct Investing customer fees in Q226, reflecting continued focus on enhancing client offering and supporting long-term growth

PBWM delivered a RoTE of 25.4% (Q325 YTD: 30.9%),

reflecting higher costs from ongoing investment to support future growth and efficiency strategy, and a higher impairment charge.

Income statement - Q326 YTD compared to Q325 YTD



Profit before tax decreased 19% to £264m



Total income increased 5% to £1,082m

, driven by higher NII from growth in deposit balances, partially offset by deposit mix, and higher net fee, commission and other income from growth in assets under management and client transactional activity



Total operating expenses increased 13% to £810m,

reflecting ongoing investment to support business growth and efficiency strategy, and inflationary headwinds, partially offset by efficiency savings

Balance sheet - 30 September 2026 compared to 31 December 2025



Client assets and liabilities increased £6.4bn to £234.0bn

, driven by net new inflow of deposits, loans and invested assets and market movements, partly offset by adverse foreign exchange impact



RWAs were stable at £8.1bn (December 2025: £8.0bn)

Barclays Investment Bank

Nine months ended

Three months ended

30.09.26

30.09.25

30.09.26

30.09.25

Income statement information

£m

% Change

£m

% Change

Net interest income

1,187

978

393

347

Net trading income

6,209

5,903

1,580

1,581

—

Net fee, commission and other income

3,719

3,382

1,156

1,155

—

Total income

11,115

10,263

3,129

3,083

Operating costs

(6,389)

(6,003)

(6)

(2,083)

(2,010)

(4)

UK regulatory levies

(25)

(22)

(14)

(3)

Litigation and conduct

(20)

—

(9)

Total operating expenses

(6,412)

(6,045)

(6)

(2,086)

(2,014)

(4)

Other net income

—

Profit before impairment

4,703

4,218

1,043

1,069

(2)

Credit impairment charges

(356)

(283)

(26)

(33)

(144)

Profit before tax

4,347

3,935

1,010

925

Attributable profit

3,035

2,798

720

723

—

Performance measures

Return on average allocated tangible equity

13.5%

12.9%

9.5%

10.1%

Average allocated tangible equity (£bn)

30.0

29.0

30.4

28.6

Income over average risk weighted assets

7.3%

6.9%

6.1%

6.3%

Cost: income ratio

58%

59%

67%

65%

Loan loss rate (bps)

As at 30.09.26

As at 31.12.25

As at 30.09.25

Balance sheet information

£bn

Gross loans and advances at amortised cost

139.6

131.0

129.8

Loans and advances to customers at amortised cost

76.4

70.0

68.6

Loans and advances to banks at amortised cost

9.7

7.4

7.5

Debt securities at amortised cost

52.8

52.9

53.0

Loans and advances at amortised cost

138.9

130.3

129.1

Trading portfolio assets

212.8

189.5

191.3

Financial assets at fair value through the income statement

198.7

183.6

263.8

Derivative financial instrument assets

308.0

251.5

222.8

Cash collateral and settlement balances

172.2

121.6

152.1

Deposits at amortised cost

166.4

156.1

152.8

Derivative financial instrument liabilities

298.2

240.6

252.0

Risk weighted assets

206.1

196.7

199.1

Period end allocated tangible equity

30.1

28.9

29.1

Nine months ended

Three months ended

30.09.26

30.09.25

30.09.26

30.09.25

Analysis of total income

£m

% Change

£m

% Change

FICC

4,199

4,405

(5)

1,012

1,256

(19)

Equities

3,387

2,522

1,010

689

Global Markets

7,586

6,927

2,022

1,945

Advisory

665

462

222

196

Equity capital markets

336

222

Debt capital markets

1,156

1,174

(2)

347

379

(8)

Banking fees and underwriting

2,157

1,858

656

646

Corporate lending

220

(82)

(13)

Transaction banking

1,332

1,258

464

424

International Corporate Bank

1,372

1,478

(7)

451

492

(8)

Investment Banking

3,529

3,336

1,107

1,138

(3)

Total income

11,115

10,263

3,129

3,083

Barclays Investment Bank

Leading Global Markets business and Investment Banking franchises operating at scale in the UK and US, including the International Corporate Bank (FTSE 350 clients and larger). Global Markets represents around two-thirds of the total Investment Bank income, while Investment Banking generates around two-thirds of fees in the US.

IB delivered a RoTE of 13.5% (Q325 YTD: 12.9%)

, driven by higher Global Markets income, Investment Banking fees and underwriting income, whilst maintaining cost and capital discipline, driving positive operating jaws and improved RWA productivity.

Income statement - Q326 YTD compared to Q325 YTD



Profit before tax increased to £4,347m (Q325 YTD: £3,935m)



IB has a diverse income profile across businesses and geographies.

The 2% appreciation of average GBP against USD adversely impacted income and profits, and positively impacted credit impairment charges and total operating expenses

Total income increased 8% to £11,115m,

including the adverse impact of strengthening average GBP against USD

Global Markets income increased 10% to £7,586m, driven by increased income in Equities

FICC income was 5% lower at £4,199m, versus a strong prior year performance, reflecting lower client activity, in rates and credit

into the second half of Q326, and further adversity in September due to the macroeconomic environment

Equities income increased 34% to £3,387m, reflecting strategic growth in Prime Financing balances, and Equity Derivatives

Investment Banking income increased

to £3,529m

Banking fees and underwriting income increased 16% to £2,157m, primarily driven by Advisory and Equity Capital Markets, up

44%

and 51% respectively, partially offset by Debt Capital Markets

ICB income decreased 7% to £1,372m. Transaction banking income increased 6% to £1,332m, as higher income from g

rowth in deposit balances was partially offset by margin compression due to change in deposits product mix.

Corporate lending income decreased to £40m, due to net losses on fair value lending and cost of hedging (c.£170m)



Total operating expenses increased to

£6,412m (Q325 YTD: £6,045m)

driven by higher performance costs, including MRT adjustments and SCAs, partially offset by efficiency savings and the impact of strengthening average GBP against USD



Credit impairment charges were £356m (Q325 YTD: £283m)

, primarily driven by higher single name charges year-on-year

Balance sheet - 30 September 2026 compared to 31 December 2025



Profit before tax increased to £4,347m (Q325 YTD: £3,935m)



Loans and advances at amortised cost increased to £138.9bn (December 2025: £130.3bn)

, driven by increased lending across Global Markets and Banking



Trading portfolio assets increased to £212.8bn (December 2025: £189.5bn)

, driven by increased trading activity to facilitate client demand in Global Markets



Financial assets at fair value through the income statement increased to £198.7bn (December 2025: £183.6bn)

, driven by increased secured lending in Global Markets



Derivative financial instrument assets increased to £308.0bn (December 2025: £251.5bn)

and liabilities increased to £298.2bn (December 2025: £240.6bn)

, reflecting an increase in client activity and mark-to-market in interest rate and equity derivatives



Deposits at amortised cost increased to £166.4bn (December 2025: £156.1bn)

, driven by growth in deposits primarily in ICB

Q326 YTD included c.£105m of fair value losses on lending and cost of hedges. Q325 YTD included c.£65m of fair value gains on lending and cost of hedging.

Barclays US Consumer Bank

Nine months ended

Three months ended

30.09.26

30.09.25

30.09.26

30.09.25

Income statement information

£m

% Change

£m

% Change

Net interest income

2,304

2,044

749

726

Net fee, commission and other income

743

584

179

215

(17)

Total income

3,047

2,628

928

941

(1)

Operating costs

(1,281)

(1,210)

(6)

(459)

(407)

(13)

UK regulatory levies

—

Litigation and conduct

(5)

(3)

(67)

(3)

—

Total operating expenses

(1,286)

(1,213)

(6)

(462)

(407)

(14)

Other net income

—

Profit before impairment

1,761

1,415

466

534

(13)

Credit impairment charges

(1,053)

(1,090)

(340)

(379)

Profit before tax

708

325

126

155

(19)

Attributable profit

521

246

118

(22)

Performance measures

Return on average allocated tangible equity

19.9%

9.4%

10.9%

13.5%

Average allocated tangible equity (£bn)

3.5

3.4

3.5

Cost: income ratio

42%

46%

50%

43%

Loan loss rate (bps)

552

489

529

505

Net interest margin

13.20%

10.96%

13.74

11.50%

As at 30.09.26

As at 31.12.25

As at 30.09.25

Balance sheet information

£bn

Gross loans and advances at amortised cost

25.5

30.6

29.8

Loans and advances to customers at amortised cost

22.3

21.1

20.0

Deposits at amortised cost

25.1

24.2

23.7

Risk weighted assets

24.3

27.4

25.8

Period end allocated tangible equity

3.3

3.8

3.5

Return on average allocated tangible equity, excluding a c.£225m Q226 gain on sale (recorded in Net fee, commission and other income), from the AA portfolio exit, was 13.6% for Q326 YTD, as a result of an adjusted attributable profit of £357m.

Q325 YTD and Q325 LLR include held for sale portfolios to remain consistent with the treatment of impairment.

Barclays US Consumer Bank

A US co-branded credit card issuer and financial services partner to 23 million customers, with a direct-to-consumer loan origination platform in Best Egg and strong online retail deposit offering. Key business updates include:



Completed the American Airlines portfolio exit and the acquisition of Best Egg in Q226, strengthening our multi-product digital-only US Consumer Bank and increasing our ability to serve a wider range of customer borrowing needs



Announced a strategic partnership with Samsung in Q226 under which Barclays is the contracted provider for a range of financial products through Samsung's digital wallet ecosystem, extending access to customers through digital channels

USCB delivered a RoTE of 19.9% (Q325 YTD: 9.4%),

reflecting a c.£225m Q226 gain on sale from the AA portfolio exit, continued operational progress, with increased income from business growth, higher net interest margin and positive operating jaws. Excluding the gain on sale of c.£225m (resulting in an adjusted attributable profit of £357m), the Q326 YTD RoTE was 13.6%.

Income statement - Q326 YTD compared to Q325 YTD



Profit before tax increased to £708m (Q325 YTD: £325m)



The 2% appreciation of average GBP against USD adversely impacted income and profits, and positively impacted credit impairment charges and total operating expenses



Total income increased 16% to £3,047m,

including the adverse impact of the strengthening of average GBP against USD. NII increased 13% to £2,304m including business growth, repricing initiatives and change in portfolio mix. Net fee, commission and other income increased 27% to £743m driven by the gain on sale from the AA portfolio, and the Best Egg acquisition



Total operating expenses increased 6% to £1,286m,

driven by the acquisitions of Best Egg and the GM portfolio, business growth and inflationary headwinds, partially offset by lower partner related expenses, ongoing efficiency savings and the strengthening of average GBP against USD



Credit impairment charges were £1,053m (Q325 YTD: £1,090m),

reflecting broadly stable underlying credit performance, the impact from the Best Egg acquisition and other portfolio changes. US cards 30 and 90 day arrears rates were stable at 2.9% (Q325: 2.9%) and 1.5% (Q325: 1.5%) respectively. The USCB total coverage ratio was 10.8% (December 2025: 11.1%

Balance sheet - 30 September 2026 compared to 31 December 2025



Loans and advances to customers at amortised cost were

£22.3bn (December 2025: £21.1bn)



Deposits at amortised cost

increased

to £25.1bn (December 2025: £24.2bn)

, with growth in retail savings which is in line with USCB's strategy to grow core deposits



RWAs decreased to £24.3bn (December 2025: £27.4bn)

, driven by a net £3.2bn reduction relating to the AA portfolio sale and Best Egg acquisition

Head Office

Nine months

ended

Three months ended

30.09.26

30.09.25

30.09.26

30.09.25

Income statement information

£m

% Change

£m

% Change

Net interest income

131

426

(69)

138

(75)

Net fee, commission and other income

(36)

(257)

(18)

(105)

Total income

169

(44)

(48)

Operating costs

(572)

(544)

(5)

(204)

(162)

(26)

UK regulatory levies

—

Litigation and conduct

(101)

(244)

(239)

Total operating expenses

(673)

(788)

(197)

(401)

Other net income

(8)

(49)

Loss before impairment

(534)

(571)

(160)

(329)

Credit impairment releases/(charges)

(6)

—

(1)

Loss before tax

(532)

(577)

(160)

(330)

Attributable loss

(421)

(537)

(118)

(299)

Performance measures

Average allocated tangible equity (£bn)

6.0

5.3

5.1

6.6

As at 30.09.26

As at 31.12.25

As at 30.09.25

Balance sheet information

£bn

Risk weighted assets

13.2

12.3

12.7

Period end allocated tangible equity

4.0

7.5

5.8

Income statement - Q326 YTD compared to Q325 YTD



Loss before tax was £532m (Q325 YTD: £577m)



Total income decreased to £95m (Q325 YTD: £169m),

driven by hedge accounting, including a c.£30m loss in Q326, and the impact of the disposal of the German consumer finance business in Q125



Total operating expenses decreased to £673m (Q325 YTD: £788m),

given Q326 YTD included a £105m charge for FCA motor finance redress. Q325 YTD included a £235m charge for FCA motor finance redress

Balance sheet - 30 September 2026 compared to 31 December 2025



RWAs increased to £13.2bn (December 2025: £12.3bn),

including the net impact of the acquisition of the long-term leasehold interest in One Churchill Place

Quarterly Results Summary

Barclays Group

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

Income statement information

£m

Net interest income

3,910

3,921

3,737

3,734

3,745

3,505

3,517

3,500

Net fee, commission and other income

3,455

4,417

4,426

3,343

3,422

3,682

4,192

3,464

Total income

7,365

8,338

8,163

7,077

7,167

7,187

7,709

6,964

Operating costs

(4,565)

(4,514)

(4,359)

(4,379)

(4,254)

(4,149)

(4,258)

(4,244)

UK regulatory levies

(11)

—

(84)

(229)

—

(96)

(227)

Litigation and conduct

(4)

(104)

(50)

(255)

(76)

(11)

(121)

Total operating expenses

(4,560)

(4,518)

(4,547)

(4,658)

(4,497)

(4,225)

(4,365)

(4,592)

Other net income/(expenses)

(25)

(9)

—

Profit before impairment

2,825

3,823

3,637

2,394

2,709

2,953

3,362

2,372

Credit impairment charges

(503)

(571)

(823)

(535)

(632)

(469)

(643)

(711)

Profit before tax

2,322

3,252

2,814

1,859

2,077

2,484

2,719

1,661

Tax charges

(422)

(731)

(638)

(388)

(365)

(552)

(621)

(448)

Profit after tax

1,900

2,521

2,176

1,471

1,712

1,932

2,098

1,213

Non-controlling interests

—

(19)

—

(18)

—

(21)

(2)

(20)

Other equity instrument holders

(254)

(243)

(244)

(258)

(255)

(252)

(232)

(228)

Attributable profit

1,646

2,259

1,932

1,195

1,457

1,659

1,864

965

Performance measures

Return on average tangible shareholders' equity

11.7%

16.1%

13.5%

8.5%

10.6%

12.3%

14.0%

7.5%

Average tangible shareholders' equity (£bn)

56.4

56.1

57.2

56.5

55.1

53.9

53.1

51.5

Cost: income ratio

62%

54%

56%

66%

63%

59%

57%

66%

Loan loss rate (bps)

Basic earnings per ordinary share

12.3p

16.7p

14.1p

8.6p

10.4p

11.7p

13.0p

6.7p

Basic weighted average number of shares (m)

13,426

13,565

13,727

13,883

14,045

14,211

14,314

14,432

Period end number of shares (m)

13,379

13,507

13,737

13,867

13,996

14,180

14,336

14,420

Period end tangible shareholders' equity (£bn)

54.8

57.2

55.6

56.8

54.9

54.5

53.4

51.5

Balance sheet and capital management

£bn

Gross loans and advances at amortised cost

459.8

450.4

449.9

441.3

437.5

428.4

430.4

429.6

Loans and advances to customers at amortised cost

373.1

359.3

358.3

352.8

346.4

339.2

338.6

337.9

Loans and advances to banks at amortised cost

10.5

12.0

8.7

9.4

8.7

9.4

8.3

Debt securities at amortised cost

70.8

73.5

68.3

68.5

70.7

69.9

71.4

68.2

Loans and advances at amortised cost

454.5

444.8

438.6

430.0

426.5

417.8

419.4

414.5

Loans and advances at amortised cost impairment coverage ratio

1.2%

1.3%

1.2%

Total assets

1,737.6

1,730.4

1,694.8

1,544.2

1,629.2

1,598.7

1,593.5

1,518.2

Deposits at amortised cost

599.3

594.4

587.6

585.6

575.3

564.5

574.3

560.7

Tangible net asset value per share

410p

423p

405p

409p

392p

384p

372p

357p

Common equity tier 1 ratio

14.2%

14.3%

14.1%

14.3%

14.1%

14.0%

13.9%

13.6%

Common equity tier 1 capital

52.4

52.2

51.2

51.1

50.3

49.5

48.8

48.6

Risk weighted assets

369.8

364.8

364.5

356.8

357.4

353.0

351.3

358.1

UK leverage ratio

4.9%

4.8%

5.1%

4.9%

5.0%

UK leverage exposure

1,344.0

1,345.6

1,321.3

1,247.3

1,285.3

1,259.8

1,252.8

1,206.5

Funding and liquidity

Group liquidity pool (£bn)

372.2

346.7

326.1

337.8

332.9

333.7

336.3

296.9

Liquidity coverage ratio

157.0%

157.7%

165.4%

170.0%

174.6%

177.7%

175.3%

172.4%

Net stable funding ratio

135.8%

135.4%

135.2%

135.3%

135.6%

136.2%

134.9%

Loan: deposit ratio

76%

75%

73%

74%

73%

74%

Customer loan: deposit ratio

64%

63%

62%

61%

62%

Refer to pages 58 to 64 for further information on how capital, RWAs and leverage are calculated.

Represents average of the last 12 spot month end ratios. In June 2025, Barclays implemented a new methodology for calculating net stress outflows related to secured financing transactions in the LCR.

From Q326, the customer loan to deposit ratio has been introduced, calculated as customer loans divided by customer deposits, to provide a customer lending-focused funding metric and improve comparability with peers.

Quarterly Results by Business

Barclays UK

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

Income statement information

£m

Net interest income

2,073

2,000

1,986

2,015

1,961

1,855

1,822

1,815

Net fee, commission and other income

276

259

272

247

292

264

252

800

Total income

2,349

2,259

2,258

2,262

2,253

2,119

2,074

2,615

Operating costs

(1,274)

(1,194)

(1,174)

(1,274)

(1,189)

(1,168)

(1,115)

(1,170)

UK regulatory levies

(5)

—

(44)

(41)

(1)

—

(43)

(36)

Litigation and conduct

(1)

(14)

(8)

(27)

(2)

(9)

Total operating expenses

(1,271)

(1,195)

(1,217)

(1,329)

(1,198)

(1,195)

(1,160)

(1,215)

Other net income

—

Profit before impairment

1,078

1,064

1,041

933

1,055

924

914

1,400

Credit impairment charges

(123)

(160)

(178)

(74)

(102)

(79)

(158)

(283)

Profit before tax

955

904

863

859

953

845

756

1,117

Attributable profit

666

623

591

706

647

580

510

781

Balance sheet information

£bn

Gross loans and advances at amortised cost

243.3

239.8

233.6

231.9

230.9

228.5

227.5

Loans and advances to customers at amortised cost

225.3

220.8

217.8

216.5

213.4

211.2

209.6

207.7

Customer deposits at amortised cost

246.1

245.6

243.9

244.6

241.5

241.3

243.1

244.2

Loan: deposit ratio

98%

97%

95%

94%

95%

94%

93%

92%

Customer loan: deposit ratio

92%

90%

89%

88%

87%

86%

85%

Risk weighted assets

90.6

89.0

87.5

85.8

86.7

86.1

85.0

84.5

Period end allocated tangible equity

12.6

12.4

12.0

11.8

11.9

11.8

11.6

Performance measures

Return on average allocated tangible equity

21.2%

20.4%

19.7%

23.8%

21.8%

19.7%

17.4%

28.0%

Average allocated tangible equity (£bn)

12.6

12.2

12.0

11.9

11.8

11.7

11.2

Cost: income ratio

54%

53%

54%

59%

53%

56%

46%

Loan loss rate (bps)

Net interest margin

3.69%

3.68%

3.72%

3.68%

3.55%

3.53%

Q424 includes the day 1 impacts from the acquisition of Tesco Bank: total Income includes a £556m gain, and credit impairment charges includes a £209m charge.

Analysis of Barclays UK

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

Analysis of total income

£m

Retail Banking

1,785

1,711

1,725

1,702

1,708

1,599

1,573

2,078

Business Banking

564

548

533

560

545

520

501

537

Total income

2,349

2,259

2,258

2,262

2,253

2,119

2,074

2,615

Analysis of credit impairment (charges)/releases

Retail Banking

(135)

(165)

(179)

(72)

(98)

(59)

(145)

(279)

Business Banking

(2)

(4)

(20)

(13)

(4)

Total credit impairment charges

(123)

(160)

(178)

(74)

(102)

(79)

(158)

(283)

Analysis of loans and advances to customers at amortised cost

£bn

Retail Banking

207.7

203.1

200.1

198.6

195.2

192.4

190.4

188.0

Business Banking

17.6

17.7

17.9

18.2

18.8

19.2

19.7

Total loans and advances to customers at amortised cost

225.3

220.8

217.8

216.5

213.4

211.2

209.6

207.7

Analysis of customer deposits at amortised cost

Retail Banking

195.2

194.5

193.1

192.7

189.3

190.8

191.4

Business Banking

50.9

51.1

50.8

51.9

52.2

52.0

52.3

52.8

Total customer deposits at amortised cost

246.1

245.6

243.9

244.6

241.5

241.3

243.1

244.2

Q424 includes the day 1 impacts from the acquisition of Tesco Bank: total Income includes a £556m gain, and credit impairment charges includes a £209m charge.

Barclays UK Corporate Bank

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

Income statement information

£m

Net interest income

437

413

394

396

383

359

342

324

Net fee, commission and other income

136

145

136

143

139

160

142

134

Total income

573

558

530

539

522

519

484

458

Operating costs

(256)

(249)

(239)

(272)

(243)

(240)

(234)

(250)

UK regulatory levies

(2)

—

(15)

(14)

—

(24)

(14)

Litigation and conduct

—

(39)

—

(1)

Total operating expenses

(258)

(249)

(254)

(286)

(234)

(279)

(258)

(265)

Other net income

—

Profit before impairment

315

309

276

253

288

240

226

193

Credit impairment charges

(2)

(16)

(3)

(1)

(5)

(12)

(19)

(40)

Profit before tax

313

293

273

252

283

228

207

153

Attributable profit

218

201

187

168

196

142

Balance sheet information

£bn

Gross loans and advances at amortised cost

33.2

31.4

31.0

30.2

29.2

28.2

27.0

25.8

Loans and advances to customers at amortised cost

33.0

31.3

30.8

30.0

29.0

27.9

26.7

25.4

Deposits at amortised cost

87.2

89.1

88.0

88.7

86.7

85.3

83.1

Customer loan: deposit ratio

38%

35%

34%

33%

31%

Risk weighted assets

27.5

26.6

27.3

26.5

25.2

25.3

24.2

23.9

Period end allocated tangible equity

3.8

3.7

3.4

3.5

3.4

3.3

Performance measures

Return on average allocated tangible equity

23.5%

21.3

19.9%

19.1%

22.8%

16.6%

17.1%

12.3%

Average allocated tangible equity (£bn)

3.7

3.8

3.5

3.4

3.3

3.2

Cost: income ratio

45%

48%

53%

45%

54%

53%

58%

Loan loss rate (bps)

Analysis of total income

£m

Corporate lending

Transaction banking

482

462

441

442

432

429

404

387

Total income

573

558

530

539

522

519

484

458

Barclays Private Bank and Wealth Management

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

Income statement information

£m

Net interest income

223

216

204

202

190

203

204

216

Net fee, commission and other income

146

150

143

146

145

135

Total income

369

366

347

348

335

348

349

351

Operating costs

(289)

(267)

(254)

(279)

(243)

(238)

(234)

(255)

UK regulatory levies

(1)

—

(3)

(7)

(1)

—

(2)

(7)

Litigation and conduct

—

(10)

—

(1)

Total operating expenses

(286)

(267)

(257)

(296)

(243)

(238)

(236)

(263)

Other net income

—

Profit before impairment

110

113

Credit impairment (charges)/releases

(5)

(2)

(1)

(2)

Profit before tax

112

122

Attributable profit

Balance sheet information

£bn

Gross loans and advances at amortised cost

16.4

15.1

15.2

14.8

14.7

Loans and advances to customers at amortised cost

16.1

14.8

14.7

14.9

14.5

Deposits at amortised cost

74.4

72.7

73.3

72.0

70.6

66.7

73.1

69.5

Risk weighted assets

8.1

8.0

8.2

8.0

7.9

8.0

7.9

Period end allocated tangible equity

1.1

Client assets and liabilities

234.0

230.2

223.8

227.6

221.5

213.4

212.4

208.9

Performance measures

Return on average allocated tangible equity

23.8%

26.9

25.5

12.6

26.4%

31.9%

34.5%

23.9%

Average allocated tangible equity (£bn)

1.1

Cost: income ratio

78%

73%

74%

85%

73%

68%

75%

Loan loss rate (bps)

(6)

(5)

(25)

Client assets and liabilities refers to deposits, lending and invested assets.

Barclays Investment Bank

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

Income statement information

£m

Net interest income

393

411

383

356

347

334

297

284

Net trading income

1,580

2,271

2,358

1,294

1,581

1,906

2,416

1,262

Net fee, commission and other income

1,156

1,276

1,287

1,142

1,155

1,067

1,160

1,061

Total income

3,129

3,958

4,028

2,792

3,083

3,307

3,873

2,607

Operating costs

(2,083)

(2,199)

(2,107)

(1,924)

(2,010)

(1,932)

(2,061)

(1,903)

UK regulatory levies

(3)

—

(22)

(159)

—

(27)

(161)

Litigation and conduct

—

(8)

(9)

(8)

(3)

(26)

Total operating expenses

(2,086)

(2,199)

(2,127)

(2,091)

(2,014)

(1,940)

(2,091)

(2,090)

Other net income

—

Profit before impairment

1,043

1,759

1,901

701

1,069

1,367

1,782

517

Credit impairment charges

(33)

(44)

(279)

(22)

(144)

(67)

(72)

(46)

Profit before tax

1,010

1,715

1,622

679

925

1,300

1,710

471

Attributable profit

720

1,204

1,111

294

723

876

1,199

247

Balance sheet information

£bn

Gross loans and advances at amortised cost

139.6

137.2

137.4

131.0

129.8

126.8

129.6

124.9

Loans and advances to customers at amortised cost

76.4

70.8

73.6

70.0

68.6

66.8

68.6

69.7

Loans and advances to banks at amortised cost

9.7

11.0

10.0

7.4

7.5

7.1

7.4

6.8

Debt securities at amortised cost

52.8

54.5

52.9

53.0

52.4

53.1

47.9

Loans and advances at amortised cost

138.9

136.3

136.5

130.3

129.1

126.3

129.1

124.4

Trading portfolio assets

212.8

208.2

189.3

189.5

191.3

186.1

185.5

166.1

Derivative financial instrument assets

308.0

302.6

285.4

251.5

263.8

279.0

253.6

291.6

Financial assets at fair value through the income statement

198.7

209.9

215.6

183.6

222.8

215.2

209.5

190.4

Cash collateral and settlement balances

172.2

182.5

189.2

121.6

152.1

145.0

148.8

111.1

Deposits at amortised cost

166.4

162.3

157.4

156.1

152.8

148.7

148.9

140.5

Derivative financial instrument liabilities

298.2

291.6

272.6

240.6

252.0

265.1

245.1

279.0

Risk weighted assets

206.1

204.1

201.7

196.7

199.1

196.4

195.9

198.8

Period end allocated tangible equity

30.1

29.6

28.9

29.1

28.7

28.9

29.3

Performance measures

Return on average allocated tangible equity

9.5%

16.0%

15.0

4.0

10.1%

12.2%

16.2%

3.4%

Average allocated tangible equity (£bn)

30.4

30.0

29.7

29.6

28.6

28.7

29.6

29.3

Income over average risk weighted assets

6.1%

7.7%

8.0%

5.5%

6.3%

6.7%

7.7%

5.2%

Cost: income ratio

67%

56%

53%

75%

65%

59%

54%

80%

Loan loss rate (bps)

Analysis of total income

£m

FICC

1,012

1,471

1,716

1,024

1,256

1,450

1,699

934

Equities

1,010

1,261

1,116

703

689

870

963

604

Global Markets

2,022

2,732

2,832

1,727

1,945

2,320

2,662

1,538

Advisory

222

188

255

214

196

123

143

189

Equity capital markets

157

Debt capital markets

347

402

407

336

379

364

431

327

Banking Fees and Underwriting

656

747

754

606

646

568

644

614

Corporate lending

(13)

(4)

156

Transaction banking

464

442

426

432

424

423

411

410

International Corporate Banking

451

479

442

459

492

419

567

455

Investment Banking

1,107

1,226

1,196

1,065

1,138

987

1,211

1,069

Total income

3,129

3,958

4,028

2,792

3,083

3,307

3,873

2,607

Barclays US Consumer Bank

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

Income statement information

£m

Net interest income

749

732

823

776

726

640

678

Net fee, commission, trading and other income

179

404

160

277

215

183

186

179

Total income

928

1,136

983

1,053

941

823

864

857

Operating costs

(459)

(442)

(380)

(427)

(407)

(396)

(407)

(433)

UK regulatory levies

—

Litigation and conduct

(3)

(2)

—

(5)

—

(3)

—

Total operating expenses

(462)

(444)

(380)

(432)

(407)

(396)

(410)

(433)

Other net income

—

Profit before impairment

466

692

603

621

534

427

454

424

Credit impairment charges

(340)

(346)

(367)

(431)

(379)

(312)

(399)

(298)

Profit before tax

126

346

236

190

155

115

126

Attributable profit

253

176

144

118

Balance sheet information

£bn

Gross loans and advances at amortised cost

25.5

25.0

30.3

30.6

29.8

27.4

28.9

30.0

Loans and advances to customers at amortised cost

22.3

21.7

21.0

21.1

20.0

18.2

18.8

20.0

Deposits at amortised cost

25.1

24.7

25.0

24.2

23.7

22.5

23.8

23.3

Risk weighted assets

24.3

27.6

27.4

25.8

24.7

25.6

26.8

Period end allocated tangible equity

3.3

3.4

3.8

3.5

3.4

3.5

3.7

Performance measures

Return on average allocated tangible equity

10.9%

30.2%

18.8%

15.8%

13.5%

10.2%

4.5%

11.2%

Average allocated tangible equity (£bn)

3.4

3.3

3.8

3.6

3.5

3.4

3.6

3.4

Cost: income ratio

50%

39%

41%

43%

48%

47%

51%

Loan loss rate (bps)

529

555

491

558

505

456

562

395

Net interest margin

13.74%

13.20%

12.76%

11.63%

11.50%

10.83%

10.53%

10.66%

Return on average allocated tangible equity, excluding a c.£225m Q226 gain on sale (recorded in Net fee, commission and other income) from the AA portfolio exit, was 10.5% for Q226, as a result of an adjusted attributable profit of £87m.

LLR includes held for sale portfolios to remain consistent with the treatment of impairment in Q424 to Q126.

Head Office

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

Income statement information

£m

Net interest income

149

(53)

(11)

138

114

174

183

Net fee, commission and other income

(18)

(88)

(105)

(43)

(109)

(107)

Total income

Operating costs

(204)

(163)

(205)

(203)

(162)

(175)

(207)

(233)

UK regulatory levies

—

(8)

—

(9)

Litigation and conduct

(1)

(107)

(13)

(239)

(2)

(3)

(84)

Total operating expenses

(197)

(164)

(312)

(224)

(401)

(177)

(210)

(326)

Other net income/(expenses)

(25)

(9)

—

(Loss)/profit before impairment

(160)

(100)

(274)

(166)

(329)

(115)

(127)

(250)

Credit impairment releases/(charges)

—

(5)

(1)

(4)

(42)

Loss before tax

(160)

(100)

(272)

(171)

(330)

(116)

(131)

(292)

Attributable loss

(118)

(97)

(206)

(152)

(299)

(114)

(124)

(318)

Balance sheet information

£bn

Risk weighted assets

13.2

12.7

12.3

12.7

12.6

12.7

16.2

Period end allocated tangible equity

4.0

6.5

5.4

7.5

5.8

5.9

4.7

2.4

Performance measures

Average allocated tangible equity (£bn)

5.1

5.6

6.8

6.7

6.6

5.5

3.8

3.4

Performance Management

Margins and balances

Nine months ended 30.09.26

Nine months ended 30.09.25

Net interest income

Average customer assets

Net interest margin

Net interest income

Average customer assets

Net interest margin

£m

Barclays UK

6,059

219,112

3.70

5,638

209,779

3.59

Barclays UK Corporate Bank

1,244

29,460

5.65

1,084

25,584

5.66

Barclays Private Bank and Wealth Management

643

15,193

5.66

597

14,735

5.42

Barclays US Consumer Bank

2,304

23,344

13.20

2,044

24,930

10.96

Group excluding IB and Head Office

10,250

287,109

4.77

9,363

275,028

4.55

Barclays Investment Bank

1,187

978

Head Office

131

426

Barclays Group Net interest income

11,568

10,767

The Group excluding IB and Head Office net interest margin increased by 22bps from 4.55% in Q325 to 4.77% in Q326 due to Group structural hedge income, partner reward updates and changes in portfolio mix in USCB.

Quarterly analysis

Q326

Q226

Q126

Q425

Q325

Net interest income

£m

Barclays UK

2,073

2,000

1,986

2,015

1,961

Barclays UK Corporate Bank

437

413

394

396

383

Barclays Private Bank and Wealth Management

223

216

204

202

190

Barclays US Consumer Bank

749

732

823

776

726

Group excluding IB and Head Office

3,482

3,361

3,407

3,389

3,260

Average customer assets

£m

Barclays UK

222,936

217,778

216,623

214,770

211,384

Barclays UK Corporate Bank

30,224

29,603

28,536

27,841

26,645

Barclays Private Bank and Wealth Management

15,620

14,936

15,022

15,105

14,802

Barclays US Consumer Bank

21,624

22,247

26,163

26,470

25,037

Group excluding IB and Head Office

290,404

284,564

286,344

284,186

277,868

Net interest margin

Barclays UK

3.69

3.68

3.72

3.68

Barclays UK Corporate Bank

5.74

5.60

5.64

5.70

Barclays Private Bank and Wealth Management

5.66

5.80

5.51

5.31

5.09

Barclays US Consumer Bank

13.74

13.20

12.76

11.63

11.50

Group excluding IB and Head Office

4.76

4.74

4.83

4.73

4.65

Structural hedge

The Group employs a structural hedge programme designed to stabilise NIM on fixed rate non-maturity balance sheet items that are behaviourally stable. As interest rates move, such balances would otherwise drive material income volatility where there is a re-pricing mismatch with floating rate assets.

The structural hedge predominantly covers non-interest-bearing current accounts and the fixed portion of instant access savings accounts as well as equity, which are invested into either floating rate customer assets or balances at central banks, creating an exposure to changes in interest rates. The structural hedge is executed primarily via a portfolio of receive-fixed, pay variable interest rate swaps, with an amortising structure so that a small portion matures and is reinvested each month at prevailing market rates. The pay-floating leg of the interest rate swaps nets down a proportion of the receive-floating income from the customer assets, leaving a receive-fixed income stream from the structural hedge.

The purpose of the structural hedge is to smooth the Group NII through time. The floating leg of the swap will re-price immediately, whereas the fixed rate yield on the portfolio reprices gradually, as a portion of the swap portfolio matures and the roll is re-invested onto new market rates.

When interest rates are higher than our structural hedge yield, the pay-floating rate will typically be higher than our average receive-fixed rate. In this scenario, when viewed in isolation, the structural hedge will be a net drag to Group NII. When floating rates are lower than our structural hedge yield, the hedge in isolation will be a net benefit.

Since the receive-fixed swaps are booked for a specific term, an element of NII is ‘locked in’. The income stabilising feature of the structural hedge provides greater net interest income certainty through the interest rate cycle.

The structural hedge is one component of a larger portfolio of interest rate risk management activities that includes non-structural hedging (e.g. pay-fixed and receive-variable flows for asset hedging), and other offsetting flows. The net risk of these positions is executed externally through interest rate swaps and managed for accounting risk (i.e. income volatility arising from the accounting mismatch of swaps at fair value through profit and loss and underlying hedged items at amortised cost) within the cash flow hedging reserve.

Overall the Group has external derivatives designated as cash flow hedges that hedge interest rate risk with a notional of £122.2bn (December 2025: £114.6bn) which reflects the structural hedge derivatives notional of £240.6bn (December 2025: £236.1bn) netted with non-structural hedging positions of £118.4bn (December 2025: £121.5bn). The majority of these interest rate swaps are cleared with Central Clearing Counterparties and margined daily with an average structural hedge duration of c.3.5 years.

Gross structural hedge contributions were £5,352m (September 2025: £4,313m). Gross structural hedge contributions primarily represent the absolute interest income earned on the fixed legs of the swaps in the structural hedge as the floating leg is offset by the base rate funding of the deposits.

Credit Risk

Loans and advances at amortised cost by geography

Total loans and advances at amortised cost in the credit risk section includes loans and advances at amortised cost to banks and loans and advances at amortised cost to customers.

The table below presents a product and geographical breakdown of loans and advances at amortised cost and the impairment allowance by stage. The table also presents stage allocation of debt securities and off-balance sheet loan commitments and financial guarantee contracts.

The impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to gross loans and advances to the extent allowance does not exceed the drawn exposure and any excess is reported on the liabilities side of the balance sheet as a provision. For wholesale portfolios, impairment allowance on undrawn exposure is reported on the liability side of the balance sheet as a provision.

Gross exposure

Impairment allowance

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

As at 30.09.26

£m

Retail mortgages

168,607

13,370

1,797

183,774

100

Retail credit cards

15,336

2,231

245

17,812

161

457

155

773

Retail other

9,209

1,705

223

11,137

106

183

181

470

Corporate loans

56,882

6,394

1,624

64,900

170

549

812

Total UK

250,034

23,700

3,889

277,623

378

830

947

2,155

Retail mortgages

1,649

264

161

2,074

Retail credit cards

19,282

2,883

1,779

23,944

400

815

1,418

2,633

Retail other

4,219

350

4,639

Corporate loans

75,248

3,615

1,892

80,755

133

292

501

Total Rest of the World

100,398

7,112

3,902

111,412

495

957

1,753

3,205

Total loans and advances at amortised cost

350,432

30,812

7,791

389,035

873

1,787

2,700

5,360

Debt securities at amortised cost

69,553

1,255

—

70,808

—

Total loans and advances at amortised cost including debt securities

419,985

32,067

7,791

459,843

884

1,797

2,700

5,381

Off-balance sheet loan commitments and financial guarantee contracts

403,993

16,478

1,166

421,637

155

225

413

Total

3,4

823,978

48,545

8,957

881,480

1,039

2,022

2,733

5,794

Net exposure

Coverage ratio

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

As at 30.09.26

£m

Retail mortgages

168,589

13,350

1,735

183,674

—

0.1

3.5

0.1

Retail credit cards

15,175

1,774

17,039

1.0

20.5

63.3

4.3

Retail other

9,103

1,522

10,667

1.2

10.7

81.2

4.2

Corporate loans

56,789

6,224

1,075

64,088

0.2

2.7

33.8

1.3

Total UK

249,656

22,870

2,942

275,468

0.2

3.5

24.4

0.8

Retail mortgages

1,646

263

136

2,045

0.2

0.4

15.5

1.4

Retail credit cards

18,882

2,068

361

21,311

2.1

28.3

79.7

11.0

Retail other

4,203

342

4,597

0.4

2.3

25.7

0.9

Corporate loans

75,172

3,482

1,600

80,254

0.1

3.7

15.4

0.6

Total Rest of the World

99,903

6,155

2,149

108,207

0.5

13.5

44.9

2.9

Total loans and advances at amortised cost

349,559

29,025

5,091

383,675

0.2

5.8

34.7

1.4

Debt securities at amortised cost

69,542

1,245

—

70,787

—

0.8

—

Total loans and advances at amortised cost including debt securities

419,101

30,270

5,091

454,462

0.2

5.6

34.7

1.2

Off-balance sheet loan commitments and financial guarantee contracts

403,838

16,253

1,133

421,224

—

1.4

2.8

0.1

Total

3,4

822,939

46,523

6,224

875,686

0.1

4.2

30.5

0.7

Includes Business Banking, which has a gross exposure of £12.5bn and an impairment allowance of £280m. This comprises £34m impairment allowance on £10.1bn Stage 1 exposure, £59m on £1.7bn Stage 2 exposure and £187m on £0.7bn Stage 3 exposure. Excluding this, total coverage for corporate loans in UK is 1.0%.

Excludes loan commitments and financial guarantees of £37.7bn carried at fair value.

Excludes other financial assets subject to impairment comprising of cash collateral and settlement balances, reverse repurchase agreements and other similar secured lending, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £275.0bn and an impairment allowance of £149m. This comprises £20m impairment allowance on £274.6bn Stage 1 exposure, £8m on £0.4bn Stage 2 exposure and £121m on £128m Stage 3 exposure.

The annualised loan loss rate is 55bps after applying the total impairment charges of £1,897m.

Purchased or originated credit-impaired (POCI) balances are no longer presented following the sale of those balances as part of the Tesco debt sale completed in September 2026. The corresponding FY25 balances of £44m are included within Stage 3 exposure as at 31.12.25.

Gross exposure

Impairment allowance

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

As at 31.12.25

£m

Retail mortgages

159,825

13,757

1,836

175,418

Retail credit cards

14,922

1,943

303

17,168

171

398

174

743

Retail other

9,867

1,512

301

11,680

178

214

490

Corporate loans

54,182

6,936

1,392

62,510

125

180

422

727

Total UK

238,796

24,148

3,832

266,776

409

772

870

2,051

Retail mortgages

1,829

131

2,032

—

Retail credit cards

18,801

2,536

1,776

23,113

395

796

1,395

2,586

Retail other

2,482

206

2,751

Corporate loans

66,671

3,702

1,767

72,140

135

382

599

Total Rest of the World

89,783

6,516

3,737

100,036

482

936

1,820

3,238

Total loans and advances at amortised cost

328,579

30,664

7,569

366,812

891

1,708

2,690

5,289

Debt securities at amortised cost

68,126

371

—

68,497

—

Total loans and advances at amortised cost including debt securities

396,705

31,035

7,569

435,309

904

1,717

2,690

5,311

Off-balance sheet loan commitments and financial guarantee contracts

410,493

16,473

817

427,783

144

240

416

Total

3,4

807,198

47,508

8,386

863,092

1,048

1,957

2,722

5,727

Net exposure

Coverage ratio

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

As at 31.12.25

£m

Retail mortgages

159,810

13,741

1,776

175,327

—

0.1

3.3

0.1

Retail credit cards

14,751

1,545

129

16,425

1.1

20.5

57.4

4.3

Retail other

9,769

1,334

11,190

1.0

11.8

71.1

4.2

Corporate loans

54,057

6,756

970

61,783

0.2

2.6

30.3

1.2

Total UK

238,387

23,376

2,962

264,725

0.2

3.2

22.7

0.8

Retail mortgages

1,827

107

2,006

0.1

—

18.3

1.3

Retail credit cards

18,406

1,740

381

20,527

2.1

31.4

78.5

11.2

Retail other

2,479

201

2,724

0.1

2.4

30.2

1.0

Corporate loans

66,589

3,567

1,385

71,541

0.1

3.6

21.6

0.8

Total Rest of the World

89,301

5,580

1,917

96,798

0.5

14.4

48.7

3.2

Total loans and advances at amortised cost

327,688

28,956

4,879

361,523

0.3

5.6

35.5

1.4

Debt securities at amortised cost

68,113

362

—

68,475

—

2.4

—

Total loans and advances at amortised cost including debt securities

395,801

29,318

4,879

429,998

0.2

5.5

35.5

1.2

Off-balance sheet loan commitments and financial guarantee contracts

410,349

16,233

785

427,367

—

1.5

3.9

0.1

Total

3,4

806,150

45,551

5,664

857,365

0.1

4.1

32.5

0.7

Includes Business Banking, which has a gross exposure of £12.4bn and an impairment allowance of £326m. This comprises £62m impairment allowance on £9.3bn Stage 1 exposure, £50m on £2.3bn Stage 2 exposure and £214m on £0.8bn Stage 3 exposure. Excluding this, total coverage for corporate loans in UK is 0.8%.

Excludes loan commitments and financial guarantees of £22.2bn carried at fair value and includes exposure relating to financial assets classified as assets held for sale.

Excludes other financial assets subject to impairment comprising of cash collateral and settlement balances, reverse repurchase agreements and other similar secured lending, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £224.1bn and an impairment allowance of £150m. This comprises £18m impairment allowance on £222.4bn Stage 1 exposure, £8m on £1.6bn Stage 2 exposure and £124m on £127m Stage 3 exposure.

The annualised loan loss rate is 52bps after applying the total impairment charges of £2,279m.

POCI balances are no longer presented following the sale of those balances as part of the Tesco debt sale completed in September 2026. The corresponding FY25 balances of £44m are included within Stage 3 exposure as at 31.12.25.

Assets held for sale

The prior period presents gross loans and advances and the related impairment allowance for the AA portfolio in USCB classified as assets held for sale in the condensed consolidated balance sheet. The sale of this portfolio was completed on 24 April 2026.

Loans and advances by product

Stage 1

Stage 2

Stage 3

Total

Gross

ECL

Coverage

Gross

ECL

Coverage

Gross

ECL

Coverage

Gross

ECL

Coverage

As at 31.12.25

£m

Retail credit cards - US

5,468

1.2

466

124

26.6

81.5

5,988

233

3.9

Corporate loans - US

2.3

33.3

—

6.1

Total Rest of the World

5,511

1.2

472

126

26.7

81.5

6,037

236

3.9

Loans

and advances at amortised cost by product

The table below presents loans and advances at amortised cost by product and stage, including Stage 2 past due balances.

Stage 2

As at 30.09.26

Stage 1

Not past due

<=30 days past due

>30 days past due

Total

Stage 3

Total

Gross exposure

£m

Retail mortgages

170,256

10,931

2,006

697

13,634

1,958

185,848

Retail credit cards

34,618

4,466

345

303

5,114

2,024

41,756

Retail other

13,428

1,782

191

2,055

293

15,776

Corporate loans

132,130

9,781

155

10,009

3,516

145,655

Total

350,432

26,960

2,697

1,155

30,812

7,791

389,035

Impairment allowance

Retail mortgages

129

Retail credit cards

561

932

145

195

1,272

1,573

3,406

Retail other

122

124

191

199

512

Corporate loans

169

282

303

841

1,313

Total

873

1,350

194

243

1,787

2,700

5,360

Net exposure

Retail mortgages

170,235

10,919

2,000

694

13,613

1,871

185,719

Retail credit cards

34,057

3,534

200

108

3,842

451

38,350

Retail other

13,306

1,658

158

1,864

15,264

Corporate loans

131,961

9,499

145

9,706

2,675

144,342

Total

349,559

25,610

2,503

912

29,025

5,091

383,675

Coverage ratio

Retail mortgages

—

0.1

0.3

0.4

0.2

4.4

0.1

Retail credit cards

1.6

20.9

42.0

64.4

24.9

77.7

8.2

Retail other

0.9

7.0

17.3

41.5

9.3

67.9

3.2

Corporate loans

0.1

2.9

6.5

15.1

3.0

23.9

0.9

Total

0.2

5.0

7.2

21.0

5.8

34.7

1.4

As at 31.12.25

Gross exposure

£m

Retail mortgages

161,65

11,072

2,033

724

13,829

1,967

177,450

Retail credit cards

33,723

3,832

317

330

4,479

2,079

40,281

Retail other

12,349

1,398

207

113

1,718

364

14,431

Corporate loans

120,853

10,409

158

10,638

3,159

134,650

Total

328,579

26,711

2,628

1,325

30,664

7,569

366,812

Impairment allowance

Retail mortgages

117

Retail credit cards

566

840

138

216

1,194

1,569

3,329

Retail other

101

126

183

233

517

Corporate loans

207

298

315

804

1,326

Total

891

1,273

177

258

1,708

2,690

5,289

Net exposure

Retail mortgages

161,637

11,063

2,029

721

13,813

1,883

177,333

Retail credit cards

33,157

2,992

179

114

3,285

510

36,952

Retail other

12,248

1,272

179

1,535

131

13,914

Corporate loans

120,646

10,111

148

10,323

2,355

133,324

Total

327,688

25,438

2,451

1,067

28,956

4,879

361,523

Coverage ratio

Retail mortgages

—

0.1

0.2

0.4

0.1

4.3

0.1

Retail credit cards

1.7

21.9

43.5

65.5

26.7

75.5

8.3

Retail other

0.8

9.0

13.5

25.7

10.7

64.0

3.6

Corporate loans

0.2

2.9

9.9

6.3

3.0

25.5

1.0

Total

0.3

4.8

6.7

19.5

5.6

35.5

1.4

Measurement uncertainty

Scenarios used to calculate the Group’s modelled ECL charge were refreshed in Q326, with the Baseline scenario reflecting the latest consensus macroeconomic forecasts available at the time of the scenario refresh. The Baseline scenario continues to reflect the volatile trade policies of the US administration and ongoing geopolitical uncertainty, compounded by ongoing tensions in the Middle East and associated risks to global energy markets.

Global growth slows modestly as higher US tariffs, retaliatory measures and persistent uncertainty disrupt trade flows, weigh on investment and dampen business confidence, though domestic demand in advanced economies remains relatively resilient. UK and US GDP growth in 2027 is expected to be 1.2% and 2.1%, respectively. Inflationary pressures remain elevated, with some tariff pass-through, higher energy prices, renewed supply-side frictions and increased transportation costs contributing to a more persistent and broad-based inflation profile. The softening in labour markets is gradual and insufficient to quickly alleviate underlying price pressures. UK and US quarterly unemployment rates peak at 5.2% and 4.3%, respectively.

The Downside scenarios have been calibrated to capture a severe escalation in geopolitical tensions, centred on a prolonged Middle East conflict, alongside intensifying global trade frictions. Early in the scenario, conflict escalates sharply with disruptions at critical maritime chokepoints, triggering severe shipping disruptions, surging insurance costs and sharp increases in oil and gas prices amid infrastructure damage. As the shock becomes protracted, firms delay investment, reassess supply chains and hoard inputs, while business and consumer confidence fall sharply. In Downside 2, UK and US GDP in 2027 falls by 3.9% and 3.8%, respectively. Inflation dynamics diverge sharply from Baseline, generating a stagflationary impulse. The deterioration in demand and investment drives a sharp increase in unemployment, initially concentrated in trade and energy exposed sectors but increasingly spilling over into services. In Downside 2, UK and US quarterly unemployment rates peak at 8.1% and 8.8%, respectively.

Monetary policy faces a difficult trade-off between persistent inflation and weakening growth. Central banks initially hike rates to ensure inflation expectations remain well anchored, but as the downturn deepens and demand forces weaken price pressures, they shift towards easing. The scenarios also incorporate climate-related risks through both physical and transition channels, including more frequent severe weather disruptions and a shift in sentiment around energy security. These effects amplify volatility, increase costs and further weigh on growth over the medium term.

In the Upside scenarios, a rise in labour force participation and higher productivity contribute to accelerated economic growth, without creating new inflationary pressures. Central banks lower interest rates stimulating private consumption and investment growth. Demand for labour increases and unemployment decreases. As geopolitical tensions ease, low inflation supports consumer purchasing power and contributes further to healthy GDP growth. The strong economic outlook and lower interest rates provide a boost to house price growth.

The methodology for estimating scenario weights involves simulating a range of future paths for UK and US GDP using historical data with the five scenarios mapped against the distribution of these future paths. The increase in the Upside weights and the reduction in the Baseline and Downside weights in Q326 was driven by improvement in UK and US GDP outlook in the Baseline scenario, moving the Baseline scenario closer to the Upside scenarios. For further details see page 44

However, the Group expects geopolitical uncertainty to remain elevated and any potential impact on corporate earnings is expected to lag. In response, the £66m¹ management adjustment introduced in Q126 within the Investment Bank has been retained.

The following tables show the key macroeconomic variables used in the five scenarios (5-year annual paths) and the weights applied to each scenario.

Excludes management adjustment of £2m related to other financial assets subject to impairment.

Macroeconomic variables used in the calculation of ECL

As at 30.09.26

2026

2027

2028

2029

2030

Baseline

UK GDP

1.3

1.2

1.6

1.7

UK unemployment

5.1

5.2

4.9

4.7

UK HPI

1.6

2.0

3.2

5.0

4.5

UK bank rate

3.8

4.3

UK CPI

3.2

2.1

1.4

2.4

1.8

US GDP

2.2

2.1

2.2

US unemployment

4.3

4.2

US HPI

1.7

1.0

1.7

US federal funds rate

3.8

4.0

US CPI

3.3

2.3

2.2

2.3

2.2

Downside 2

UK GDP

1.1

(3.9)

0.3

2.3

1.0

UK unemployment

5.4

7.6

7.9

7.1

6.2

UK HPI

(4.2)

(25.4)

3.1

10.4

5.6

UK bank rate

3.9

5.1

4.7

4.5

UK CPI

5.1

6.7

1.0

0.5

1.1

US GDP

1.9

(3.8)

(1.1)

1.8

2.0

US unemployment

4.8

8.1

8.5

7.5

6.4

US HPI

(0.1)

(10.2)

3.8

6.3

3.0

US federal funds rate

3.8

4.8

4.4

4.3

US CPI

4.6

5.5

1.8

2.0

Downside 1

UK GDP

1.2

(1.3)

1.0

2.0

1.4

UK unemployment

5.2

6.4

6.6

6.0

5.5

UK HPI

(1.3)

(12.4)

3.2

7.7

5.0

UK bank rate

3.9

4.7

4.5

4.4

UK CPI

4.1

4.3

1.2

1.5

US GDP

2.0

(0.9)

0.5

2.0

2.1

US unemployment

4.6

6.2

6.4

5.8

5.3

US HPI

0.8

(4.7)

2.7

4.0

2.3

US federal funds rate

3.8

4.5

4.3

US CPI

3.9

2.0

2.1

Upside 2

UK GDP

1.5

3.5

3.4

2.8

2.4

UK unemployment

5.0

4.5

4.4

4.0

3.8

UK HPI

1.9

14.0

6.9

4.0

4.2

UK bank rate

3.8

3.1

3.3

UK CPI

2.7

1.2

1.3

1.2

US GDP

2.2

3.0

2.8

US unemployment

4.2

3.6

3.5

US HPI

3.9

4.7

5.2

4.8

US federal funds rate

3.7

3.3

3.1

US CPI

2.8

1.6

Average Real GDP seasonally adjusted change in year.

Average UK unemployment rate 16-year+.

Change in year-end UK HPI = Halifax HPI Meth2 All Houses, All Buyers index, relative to prior year-end.

Average rate.

Change in year-end UK CPI = Harmonised Index of Consumer Prices, relative to prior year-end.

Average US civilian unemployment rate 16-year+.

Change in year-end US HPI = FHFA House Price Index, relative to prior year-end.

Change in year-end US CPI = Consumer Price Index, relative to prior year-end.

Upside 1

UK GDP

1.4

2.3

2.5

2.2

2.0

UK unemployment

5.1

4.8

4.5

4.3

UK HPI

1.7

7.9

5.1

4.5

4.3

UK bank rate

3.8

4.0

3.7

3.8

UK CPI

3.0

1.6

1.3

1.8

1.5

US GDP

2.2

2.6

2.5

US unemployment

4.3

4.0

3.9

US HPI

2.8

3.4

3.2

US federal funds rate

3.8

3.6

US CPI

3.0

1.9

2.0

1.9

Average Real GDP seasonally adjusted change in year.

Average UK unemployment rate 16-year+.

Change in year-end UK HPI = Halifax HPI Meth2 All Houses, All Buyers index, relative to prior year-end.

Average rate.

Change in year-end UK CPI = Harmonised Index of Consumer Prices, relative to prior year-end.

Average US civilian unemployment rate 16-year+.

Change in year-end US HPI = FHFA House Price Index, relative to prior year-end.

Change in year-end US CPI = Consumer Price Index, relative to prior year-end.

Macroeconomic variables used in the calculation of ECL

As at 30.06.26

2026

2027

2028

2029

2030

Baseline

UK GDP

0.4

1.1

1.4

1.5

UK unemployment

5.3

5.0

4.9

UK HPI

1.3

1.6

3.9

3.0

3.9

UK bank rate

4.1

4.4

4.3

US GDP

1.7

2.0

2.1

US unemployment

4.4

4.3

US HPI

2.1

2.4

US federal funds rate

3.7

3.8

Downside 2

UK GDP

(0.5)

(4.1)

1.9

1.7

1.0

UK unemployment

6.0

7.8

6.9

6.0

UK HPI

(12.0)

(19.3)

6.7

9.3

4.6

UK bank rate

4.2

5.1

4.6

4.5

US GDP

0.5

(4.3)

—

2.1

1.6

US unemployment

5.5

8.5

8.3

7.2

6.1

US HPI

(3.1)

(6.3)

5.7

5.0

2.9

US federal funds rate

3.8

4.9

4.3

Downside 1

UK GDP

(0.1)

(1.6)

1.6

1.5

1.2

UK unemployment

5.6

6.6

6.4

5.9

5.4

UK HPI

(5.4)

(9.2)

5.3

6.1

4.3

UK bank rate

4.1

4.7

4.5

US GDP

1.1

(1.2)

1.1

2.1

1.9

US unemployment

5.0

6.4

6.3

5.8

5.2

US HPI

(0.5)

(2.1)

4.0

3.7

2.7

US federal funds rate

3.8

4.2

4.1

4.0

Upside 2

UK GDP

0.9

3.8

3.2

2.6

2.3

UK unemployment

5.1

4.6

4.1

4.0

UK HPI

4.1

14.2

6.8

2.7

3.8

UK bank rate

4.0

3.8

3.0

3.1

3.3

US GDP

1.8

3.2

2.9

2.8

US unemployment

4.2

3.7

3.6

US HPI

4.9

4.3

5.3

4.9

US federal funds rate

3.5

3.0

2.8

Upside 1

UK GDP

0.6

2.4

2.3

2.0

1.9

UK unemployment

5.2

4.9

4.6

4.5

UK HPI

2.7

7.8

5.4

2.9

3.9

UK bank rate

4.0

4.1

3.5

3.6

3.8

US GDP

1.8

2.6

2.5

US unemployment

4.3

4.0

US HPI

3.5

3.2

3.8

3.6

US federal funds rate

3.5

3.3

Average

Real G

DP seasonally adjusted change in year.

Average UK unemployment rate 16-year+.

Change in year-end UK HPI = Halifax HPI Meth2 All Houses, All Buyers index, relative to prior year-end.

Average rate.

Average US civilian unemployment rate 16-year+.

Change in year-end US HPI = FHFA House Price Index, relative to prior year-end.

As at 31.12.25

2025

2026

2027

2028

2029

Baseline

UK GDP

1.5

1.1

1.4

UK unemployment

4.7

4.9

4.8

4.7

UK HPI

1.5

2.9

2.5

4.3

3.8

UK bank rate

4.2

3.4

3.5

3.6

US GDP

2.1

2.0

US unemployment

4.2

4.5

4.4

US HPI

3.2

1.7

1.9

2.6

US federal funds rate

4.2

3.4

3.3

3.5

Downside 2

UK GDP

1.5

(2.5)

(1.2)

2.8

1.1

UK unemployment

4.7

5.8

7.7

6.9

5.7

UK HPI

1.5

(24.9)

(5.1)

9.6

14.2

UK bank rate

4.2

2.3

0.5

0.4

1.1

US GDP

2.1

(2.7)

(2.8)

1.6

2.4

US unemployment

4.2

5.7

8.0

7.9

5.9

US HPI

3.2

(8.2)

(1.7)

7.2

7.7

US federal funds rate

4.2

3.6

2.4

1.4

1.2

Downside 1

UK GDP

1.5

(0.7)

0.1

2.1

1.3

UK unemployment

4.7

5.3

6.3

5.8

5.2

UK HPI

1.5

(11.8)

(1.3)

6.9

8.9

UK bank rate

4.2

2.9

2.0

1.9

2.4

US GDP

2.1

(0.3)

(0.4)

1.8

2.2

US unemployment

4.2

5.1

6.2

6.1

5.1

US HPI

3.2

(3.3)

0.1

4.9

5.1

US federal funds rate

4.2

3.6

2.8

2.4

Upside 2

UK GDP

1.5

2.7

3.7

2.9

2.4

UK unemployment

4.7

4.3

4.0

3.9

3.8

UK HPI

1.5

11.9

8.4

5.1

4.1

UK bank rate

4.2

3.1

2.3

2.6

US GDP

2.1

2.8

3.1

2.8

US unemployment

4.2

3.9

3.7

US HPI

3.2

6.2

4.7

4.8

4.9

US federal funds rate

4.2

3.0

2.5

Upside 1

UK GDP

1.5

1.9

2.6

2.2

1.9

UK unemployment

4.7

4.6

4.4

4.3

UK HPI

1.5

7.4

5.4

4.7

3.9

UK bank rate

4.2

3.2

2.8

3.1

US GDP

2.1

2.4

2.6

2.4

US unemployment

4.2

4.1

US HPI

3.2

4.0

3.3

3.7

US federal funds rate

4.2

3.3

2.8

3.0

Average Real GDP seasonally adjusted change in year.

Average UK unemployment rate 16-year+.

Change in year-end UK HPI = Halifax HPI Meth2 All Houses, All Buyers index, relative to prior year-end.

Average rate.

Average US civilian unemployment rate 16-year+.

Change in year-end US HPI = FHFA House Price Index, relative to prior year-end.

Scenario weighting

Upside 2

Upside 1

Baseline

Downside 1

Downside 2

As at 30.09.26

Scenario weighting

16.6

28.0

36.4

12.1

6.9

As at 30.06.26

Scenario weighting

13.7

27.3

39.5

12.5

7.0

As at 31.12.25

Scenario weighting

14.4

27.4

38.5

12.7

7.0

Treasury and Capital Risk

Regulatory minimum requirements

Capital

As at 30 September 2026, the Group’s Overall Capital Requirement for CET1, excluding any applicable PRA buffer, was 12.2% and comprised a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.7% Pillar 2A requirement and a 1.0% Countercyclical Capital Buffer (CCyB).

The Group’s CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. The buffer rates set by other national authorities for non-UK exposures are not currently material.

The Group’s Pillar 2A requirement is 4.8% with at least 56.25% to be met with CET1 capital, equating to 2.7% of RWAs. The Pillar 2A requirement, based on a point in time assessment, has been set as a proportion of RWAs and is subject to at least annual review.

The Group’s CET1 target ratio of 13-14% takes into account minimum capital requirements and applicable buffers. The Group remains above its minimum capital regulatory requirements and applicable buffers.

Leverage

As at 30 September 2026, the Group was subject to a UK leverage ratio requirement of 4.1%. This comprised the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB) of 0.3%. The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter.

MREL

As at 30 September 2026, the Group was required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.8% Pillar 2A equating to 25.5% of RWAs; and (ii) 6.75% of leverage exposures. CET1 capital cannot be counted towards both MREL and the buffers, meaning that the buffers, including any applicable PRA buffer, will effectively be applied above MREL requirements.

Significant regulatory updates in the period

In January 2026, the PRA confirmed the final implementation timetable for the UK Basel 3.1 framework, reaffirming that Basel 3.1 will be implemented from 1 January 2027. From the same date, the Group’s Overall Capital Requirement will reduce, reflecting a 59bps reduction in the Pillar 2A requirement on a CET1 basis.

The PRA also confirmed its approach to the Fundamental Review of the Trading Book (FRTB), under which implementation of the Internal Models Approach (IMA) will be deferred to 1 January 2028, while all other FRTB components will take effect from 1 January 2027.

Capital ratios

As at 30.09.26

As at 30.06.26

As at 31.12.25

CET1

14.2%

14.3%

17.8%

18.0%

17.9%

Total regulatory capital

19.9%

20.3%

20.4%

MREL ratio as a percentage of total RWAs

35.2%

36.7%

35.8%

Own funds and eligible liabilities

£m

Total equity excluding non-controlling interests per the balance sheet

77,100

79,358

77,784

Less: other equity instruments (recognised as AT1 capital)

(13,275)

(12,725)

Adjustment to retained earnings for foreseeable ordinary share dividends

(705)

(1,000)

(778)

Adjustment to retained earnings for foreseeable repurchase of shares

(316)

—

(271)

Adjustment to retained earnings for foreseeable other equity coupons

(45)

(38)

(36)

Other regulatory adjustments and deductions

Additional value adjustments (PVA)

(2,108)

(2,086)

(1,956)

Goodwill and intangible assets

(8,769)

(8,845)

(8,255)

Deferred tax assets that rely on future profitability excluding temporary differences

(828)

(892)

(1,069)

Fair value reserves related to gains or losses on cash flow hedges

3,936

1,548

666

Excess of expected losses over impairment

(618)

(505)

(436)

Gains or losses on liabilities at fair value resulting from own credit

707

577

904

Defined benefit pension fund assets

(2,468)

(2,407)

(2,398)

Direct and indirect holdings by an institution of own CET1 instruments

(8)

(6)

(14)

Other regulatory adjustments

(237)

(186)

(346)

CET1 capital

52,366

52,243

51,070

AT1 capital

Capital instruments and related share premium accounts

13,286

12,758

Other regulatory adjustments and deductions

(10)

(33)

AT1 capital

13,276

13,275

12,725

T1 capital

65,642

65,519

63,795

T2 capital

Capital instruments and related share premium accounts

8,188

8,479

8,835

Qualifying T2 capital (including minority interests) issued by subsidiaries

Other regulatory adjustments and deductions

(140)

(118)

(71)

Total regulatory capital

73,737

73,929

72,614

Less : Ineligible T2 capital (including minority interests) issued by subsidiaries

(47)

(49)

(55)

Eligible liabilities

56,549

59,973

55,106

Total own funds and eligible liabilities

130,239

133,852

127,665

Total RWAs

369,753

364,764

356,774

As at 30 September 2026, the Group's MREL requirement, excluding any applicable PRA buffer, was to hold £112.9bn of own funds and eligible liabilities equating to 30.5% of RWAs. The Group remains above its MREL regulatory requirement including any applicable PRA buffer

Movement in CET1 capital

Three months ended 30.09.26

Nine months ended 30.09.26

£m

Opening CET1 capital

52,243

51,070

Profit for the period attributable to equity holders

1,900

6,578

Own credit relating to derivative liabilities

(5)

Ordinary share dividends paid and foreseen

(500)

(1,500)

Purchased and foreseeable share repurchase

(1,000)

(2,500)

Other equity coupons paid and foreseen

(262)

(751)

Increase in retained regulatory capital generated from earnings

133

1,830

Net impact of share schemes

153

Fair value through other comprehensive income reserve

(67)

Currency translation reserve

(36)

183

Other reserves

(12)

(20)

Increase in other qualifying reserves

241

Pension remeasurements within reserves

Defined benefit pension fund asset deduction

(60)

(70)

Net impact of pensions

(1)

(35)

Additional value adjustments (PVA)

(22)

(152)

Goodwill and intangible assets

(515)

Deferred tax assets that rely on future profitability excluding those arising from temporary differences

241

Excess of expected loss over impairment

(113)

(182)

Direct and indirect holdings by an institution of own CET1 instruments

(2)

Other regulatory adjustments

(50)

(138)

Decrease in regulatory capital due to adjustments and deductions

(47)

(740)

Closing CET1 capital

52,366

CET1 capital increased by £1.3bn to £52.4bn (December 2025: £51.1bn). Significant movements in the period were:

•

£6.6bn of capital generated from profit partially offset by distributions of £4.8bn comprising:

–

£2.5bn share buybacks including the now completed £1.5bn share buyback announced with the FY25 and Q126 results and the ongoing £1.0bn share buyback announced with Q226 results

–

£1.5bn of ordinary share dividends paid and foreseen reflecting the £0.8bn half year dividend paid in September 2026 and a £0.7bn accrual towards the total 2026 dividend

–

£0.8bn of equity coupons paid and foreseen

•

£0.7bn decrease due to regulatory adjustments and deductions including £0.5bn of goodwill and intangibles deductions primarily driven by the Best Egg acquisition

RWAs by risk type and business

Credit risk

Counterparty credit risk

Market Risk

Operational risk

Total RWAs

STD

IRB

STD

IRB

Settlement Risk

CVA

STD

IMA

As at 30.09.26

£m

Barclays UK

16,982

59,528

134

—

144

—

13,804

90,636

Barclays UK Corporate Bank

4,507

18,766

282

—

252

3,530

27,452

Barclays Private Bank & Wealth Management

5,104

588

126

—

170

2,062

8,118

Barclays Investment Bank

44,591

53,088

23,774

23,137

330

2,475

13,449

19,947

25,275

206,066

Barclays US Consumer Bank

17,966

967

—

5,394

24,327

Head Office

5,818

5,935

—

277

1,090

13,154

Barclays Group

94,968

138,872

24,132

23,452

330

2,525

13,920

20,399

51,155

369,753

As at 30.06.26

Barclays UK

16,987

57,919

118

—

135

—

13,804

89,005

Barclays UK Corporate Bank

3,866

18,522

260

—

274

3,530

26,568

Barclays Private Bank & Wealth Management

5,002

570

128

—

185

2,062

8,020

Barclays Investment Bank

44,721

51,050

25,723

22,591

336

2,566

12,110

19,772

25,275

204,144

Barclays US Consumer Bank

17,894

1,016

—

5,394

24,304

Head Office

5,538

5,883

—

175

1,090

12,723

Barclays Group

94,008

134,960

26,067

22,889

336

2,613

12,473

20,263

51,155

364,764

As at 31.12.25

Barclays UK

16,731

55,037

132

—

177

—

13,697

85,825

Barclays UK Corporate Bank

3,878

18,341

312

343

3,510

26,509

Barclays Private Bank & Wealth Management

4,981

580

112

—

240

2,054

8,036

Barclays Investment Bank

44,961

49,750

21,986

19,442

165

3,030

12,018

20,111

25,238

196,701

Barclays US Consumer Bank

21,050

1,004

—

5,393

27,448

Head Office

5,405

5,439

—

219

1,127

12,255

Barclays Group

97,006

130,151

22,320

19,787

166

3,088

12,484

20,753

51,019

356,774

Movement analysis of RWAs

Credit risk

Counterparty credit risk

Market risk

Operational risk

Total RWAs

£m

RWAs as at 31.12.25

227,157

45,361

33,237

51,019

356,774

Book size

10,270

5,196

900

136

16,502

Acquisitions and disposals

(3,192)

—

(3,192)

Book quality

(574)

(61)

—

(635)

Model updates

—

(289)

—

(289)

Methodology and policy

(689)

—

(660)

Foreign exchange movements

868

203

182

—

1,253

Total RWA movements

6,683

5,078

1,082

136

12,979

RWAs as at 30.09.26

233,840

50,439

34,319

51,155

369,753

Foreign exchange movements does not include the impact of foreign exchange for modelled market risk or operational risk.

Total RWAs increased £13.0bn to £369.8bn (December 2025: £356.8bn) primarily driven by:

Credit risk RWAs increased £6.7bn:

•

A £10.3bn increase in book size primarily reflecting lending growth in UK businesses and increased lending within IB; partially offset by

•

A £3.2bn decrease in acquisitions and disposals reflecting the net impact of the AA portfolio exit and the Best Egg acquisition

Counterparty credit risk RWAs increased £5.1bn primarily driven by higher activity in Global Markets

Leverage ratios

As at 30.09.26

As at 30.06.26

As at 31.12.25

£m

UK leverage ratio

4.9%

5.1%

T1 capital

65,642

65,519

63,795

UK leverage exposure

1,344,015

1,345,596

1,247,313

Average UK leverage ratio

4.6%

4.7%

Average T1 capital

64,449

63,787

63,277

Average UK leverage exposure

1,387,668

1,393,843

1,358,364

Although the leverage ratio is expressed in terms of T1 capital, the leverage ratio buffers and 75% of the minimum requirement must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £7.1bn and against the 0.3% CCLB was £4.0bn.

Condensed Consolidated Financial Statements

Condensed consolidated income statement (unaudited)

Nine months

ended

30.09.26

Nine months

ended

30.09.25

£m

Total income

23,866

22,063

Operating expenses excluding UK regulatory levies & litigation and conduct

(13,438)

(12,661)

UK regulatory levies

(95)

(84)

Litigation and conduct

(92)

(342)

Operating expenses

(13,625)

(13,087)

Other net income

Profit before impairment

10,285

9,024

Credit impairment charges

(1,897)

(1,744)

Profit before tax

8,388

7,280

Tax charge

(1,791)

(1,538)

Profit after tax

6,597

5,742

Attributable to:

Shareholders of the parent

5,837

4,980

Other equity holders

741

739

Equity holders of the parent

6,578

5,719

Non-controlling interests

Profit after tax

6,597

5,742

Earnings per share

Basic earnings per ordinary share

43.0p

35.1p

Condensed consolidated balance sheet (unaudited)

As at 30.09.26

As at 31.12.25

Assets

£m

Cash and balances at central banks

253,290

229,752

Cash collateral and settlement balances

179,396

130,532

Debt securities at amortised cost

70,787

68,475

Loans and advances at amortised cost to banks

10,526

8,638

Loans and advances at amortised cost to customers

373,149

352,885

Reverse repurchase agreements and other similar secured lending at amortised cost

12,051

17,622

Trading portfolio assets

215,985

190,061

Financial assets at fair value through the income statement

201,717

186,857

Derivative financial instruments

308,971

252,459

Financial assets at fair value through other comprehensive income

82,203

74,394

Investments in associates and joint ventures

751

739

Goodwill and intangible assets

8,994

8,284

Current tax assets

494

276

Deferred tax assets

5,654

4,992

Assets included in a disposal group classified as held for sale

—

5,932

Other assets

13,612

12,267

Total assets

1,737,580

1,544,165

Liabilities

Deposits at amortised cost from banks

15,783

20,413

Deposits at amortised cost from customers

583,476

565,200

Cash collateral and settlement balances

178,471

117,583

Repurchase agreements and other similar secured borrowings at amortised cost

29,269

25,170

Debt securities in issue

119,085

119,033

Subordinated liabilities

10,638

12,954

Trading portfolio liabilities

84,114

57,737

Financial liabilities designated at fair value

327,268

294,108

Derivative financial instruments

298,339

240,808

Current tax liabilities

992

868

Deferred tax liabilities

Other liabilities

12,578

12,042

Total liabilities

1,660,026

1,465,929

Equity

Called up share capital and share premium

4,171

4,178

Other equity instruments

13,275

12,725

Other reserves

(1,070)

1,628

Retained earnings

60,724

59,253

Total equity excluding non-controlling interests

77,100

77,784

Non-controlling interests

454

452

Total equity

77,554

78,236

Total liabilities and equity

1,737,580

1,544,165

Condensed consolidated statement of changes in equity (unaudited)

Called up share capital and share premium

Other equity instruments

Other reserves

Retained earnings

Total

Non-controlling interests

Total equity

Nine months ended 30.09.2026

£m

Balance as at 1 January 2026

4,178

12,725

1,628

59,253

77,784

452

78,236

Profit after tax

—

741

—

5,837

6,578

6,597

Currency translation movements

—

183

—

183

—

183

Fair value through other comprehensive income reserve

—

Cash flow hedges

—

(3,270)

—

(3,270)

—

(3,270)

Retirement benefit remeasurements

—

Own credit

—

200

—

200

—

200

Total comprehensive income for the period

—

741

(2,853)

5,872

3,760

3,779

Employee share schemes and hedging thereof

127

—

603

730

—

730

Issue and redemption of other equity instruments

—

527

—

527

—

527

Other equity instruments coupon paid

—

(741)

—

(741)

—

(741)

Redemption of preference shares

—

Vesting of employee share schemes net of purchases

—

(963)

(948)

—

(948)

Dividends paid

—

(1,564)

(19)

(1,583)

Repurchase of shares

(134)

—

134

(2,469)

—

(2,469)

Other movements

—

(8)

Balance as at 30 September 2026

4,171

13,275

(1,070)

60,724

77,100

454

77,554

Three months ended 30.09.2026

£m

Balance as at 1 July 2026

4,186

13,275

1,493

60,404

79,358

453

79,811

Profit after tax

—

254

—

1,646

1,900

—

1,900

Currency translation movements

—

(36)

—

(36)

—

(36)

Fair value through other comprehensive income reserve

—

(67)

—

(67)

—

(67)

Cash flow hedges

—

(2,388)

—

(2,388)

—

(2,388)

Retirement benefit remeasurements

—

Own credit

—

(134)

—

(134)

—

(134)

Total comprehensive income for the period

—

254

(2,625)

1,705

(666)

—

(666)

Employee share schemes and hedging thereof

—

124

142

—

142

Issue and redemption of other equity instruments

—

Other equity instruments coupon paid

—

(254)

—

(254)

—

(254)

Vesting of employee shares scheme net of purchases

—

(15)

—

Dividends paid

—

(795)

—

(795)

Repurchase of shares

(33)

—

(688)

—

(688)

Other movements

—

(11)

(8)

(7)

Balance as at 30 September 2026

4,171

13,275

(1,070)

60,724

77,100

454

77,554

As at As at 30.09.2026

As at As at 31.12.2025

Other Reserves

£m

Currency translation reserve

2,676

2,493

Fair value through other comprehensive income reserve

(1,067)

(1,100)

Cash flow hedging reserve

(3,936)

(666)

Own credit reserve

(783)

(990)

Other reserves and treasury shares

2,040

1,891

Total

(1,070)

1,628

Appendix: Non-IFRS Performance Measures

The

Group’s management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements, as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.

However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.

Non-IFRS performance measures glossary

Measure

Definition

Loan: deposit ratio

Loan: deposit ratio is calculated as total loans and advances at amortised cost (including debt securities) divided by total deposits at amortised cost.

Customer Loan: deposit ratio

Customer loans and advances at amortised cost divided by customer deposits at amortised cost.

Period end tangible equity refers to:

Period end tangible shareholders' equity (for Barclays Group)

Shareholders' equity attributable to ordinary shareholders of the parent, adjusted for the deduction of goodwill and intangible assets.

Period end allocated tangible equity (for businesses)

Allocated tangible equity is calculated as 13.5% (2025: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Barclays Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Barclays Group’s tangible shareholders’ equity and the amounts allocated to businesses.

Average tangible equity refers to:

Average tangible shareholders’ equity (for Barclays Group)

Calculated as the average of the previous month’s period end tangible shareholders' equity and the current month’s period end tangible shareholders' equity. The average tangible shareholders’ equity for the period is the average of the monthly averages within that period.

Average allocated tangible equity (for businesses)

Calculated as the average of the previous month’s period end allocated tangible equity and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period.

Return on tangible equity (RoTE) refers to:

Return on average tangible shareholders’ equity (for Barclays Group)

Annualised Group attributable profit, as a proportion of average tangible shareholders’ equity. The components of the calculation have been included on page 71.

Return on average allocated tangible equity (for businesses)

Annualised business attributable profit, as a proportion of that business's average allocated tangible equity. The components of the calculation have been included on pages 72 to 73.

Operating costs

A measure of total operating expenses excluding litigation and conduct charges and UK regulatory levies.

Cost: income ratio

Total operating expenses divided by total income.

Loan loss rate

Quoted in basis points and represents total impairment charges divided by total gross loans and advances held at amortised cost (including portfolios reclassified to assets held for sale) at the balance sheet date. The components of the calculation have been included on pages 74 to 76.

Net interest margin

Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 42.

Tangible net asset value per share

Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 79.

Profit before impairment

Calculated by excluding credit impairment charges or releases from profit before tax.

Net New Assets Under Management

The net inflows and outflows of client balances within Discretionary Portfolio Management and Advisory mandates. Excludes market performance and foreign exchange translation but includes reinvested dividend payments.

Assets under Management (AUM)

Total market value of client investment balances managed within investment mandates where Barclays provides discretionary portfolio management or advisory services. Total Assets Under Management excludes uninvested cash held under an investment mandate and reported within deposits.

Assets under Supervision (AUS)

Total market value of client investment balances where Barclays provides custodian or transactional services.

Group net interest income excluding Barclays Investment Bank and Head Office

A measure of Barclays Group net interest income, excluding the net interest income reported in Barclays Investment Bank and Head Office.

Income over average risk weighted assets

Represents total income as a proportion of average risk weighted assets. Average risk weighted assets calculated as the average of the previous month’s period end risk weighted assets and the

current month’s period end risk weighted assets. Average risk weighted assets for the period is the average of the monthly averages within that period.

Returns

Nine months ended 30.09.26

Barclays UK

Barclays UK Corporate Bank

Barclays Private Bank and Wealth Management

Barclays Investment Bank

Barclays US Consumer Bank

Head Office

Barclays Group

Return on average tangible equity

£m

Attributable profit/(loss)

1,880

606

216

3,035

521

(421)

5,837

£bn

Average equity

16.2

3.7

1.2

30.0

4.2

9.9

65.2

Average goodwill and intangibles

(3.9)

—

(0.1)

—

(0.7)

(3.9)

(8.6)

Average tangible equity

12.3

3.7

1.1

30.0

3.5

6.0

56.6

Return on average tangible equity

20.4%

21.6%

25.4%

13.5%

19.9%

n/m

13.8%

Nine months ended 30.09.25

Barclays UK

Barclays UK Corporate Bank

Barclays Private Bank and Wealth Management

Barclays Investment Bank

Barclays US Consumer Bank

Head Office

Barclays Group

Return on average tangible equity

£m

Attributable profit/(loss)

1,737

480

256

2,798

246

(537)

4,980

£bn

Average equity

15.8

3.4

1.2

29.0

4.1

8.8

62.3

Average goodwill and intangibles

(4.0)

—

(0.1)

—

(0.6)

(3.6)

(8.3)

Average tangible equity

11.8

3.4

1.1

29.0

3.5

5.3

54.0

Return on average tangible equity

19.6%

18.8%

30.9%

12.9%

9.4%

n/m

12.3%

Barclays Group

Return on average tangible shareholders' equity

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Attributable profit

1,646

2,259

1,932

1,195

1,457

1,659

1,864

965

£bn

Average shareholders' equity

65.3

64.8

65.5

64.8

63.3

62.1

61.4

59.7

Average goodwill and intangibles

(8.9)

(8.7)

(8.3)

(8.2)

(8.3)

(8.2)

Average tangible shareholders' equity

56.4

56.1

57.2

56.5

55.1

53.9

53.1

51.5

Return on average tangible shareholders' equity

11.7%

16.1%

13.5%

8.5%

10.6%

12.3%

14.0%

7.5%

Barclays UK

Return on average allocated tangible equity

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Attributable profit

666

623

591

706

647

580

510

781

£bn

Average allocated equity

16.5

16.2

15.9

15.8

15.7

15.1

Average goodwill and intangibles

(3.9)

(4.0)

(3.9)

(4.0)

(3.9)

Average allocated tangible equity

12.6

12.2

12.0

11.9

11.8

11.7

11.2

Return on average allocated tangible equity

21.2%

20.4%

19.7%

23.8%

21.8%

19.7%

17.4%

28.0%

Barclays UK Corporate Bank

Return on average allocated tangible equity

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Attributable profit

218

201

187

168

196

142

£bn

Average allocated equity

3.7

3.8

3.5

3.4

3.3

3.2

Average goodwill and intangibles

—

Average allocated tangible equity

3.7

3.8

3.5

3.4

3.3

3.2

Return on average allocated tangible equity

23.5%

21.3%

19.9%

19.1%

22.8%

16.6%

17.1%

12.3%

Barclays Private Bank and Wealth Management

Return on average allocated tangible equity

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Attributable profit

£bn

Average allocated equity

1.2

Average goodwill and intangibles

(0.1)

Average allocated tangible equity

1.1

Return on average allocated tangible equity

23.8%

26.9%

25.5%

12.6%

26.4%

31.9%

34.5%

23.9%

Barclays Investment Bank

Return on average allocated tangible equity

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Attributable profit

720

1,204

1,111

294

723

876

1,199

247

£bn

Average allocated equity

30.4

30.0

29.7

29.6

28.6

28.7

29.6

29.3

Average goodwill and intangibles

—

Average allocated tangible equity

30.4

30.0

29.7

29.6

28.6

28.7

29.6

29.3

Return on average allocated tangible equity

9.5%

16.0%

15.0%

4.0%

10.1%

12.2%

16.2%

3.4%

Barclays US Consumer Bank

Return on average allocated tangible equity

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Attributable profit

253

176

144

118

£bn

Average allocated equity

4.3

4.1

4.3

4.2

4.0

4.2

4.0

Average goodwill and intangibles

(0.9)

(0.8)

(0.5)

(0.6)

(0.5)

(0.6)

Average allocated tangible equity

3.4

3.3

3.8

3.6

3.5

3.4

3.6

3.4

Return on average allocated tangible equity

10.9%

30.2%

18.8%

15.8%

13.5%

10.2%

4.5%

11.2%

Loan loss rates

Nine months ended 30.09.26

Barclays UK

Barclays UK Corporate Bank

Barclays Private Bank and Wealth Management

Barclays Investment Bank

Barclays US Consumer Bank

Head Office

Barclays Group

Loan loss rate

£m

Credit impairment (charges)/ releases

(461)

(21)

(8)

(356)

(1,053)

(1,897)

£bn

Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)

243.3

33.2

16.4

139.6

25.5

1.8

459.8

Loan loss rate (bps)

552

n/m

Nine months ended 30.09.25

Barclays UK

Barclays UK Corporate Bank

Barclays Private Bank and Wealth Management

Barclays Investment Bank

Barclays US Consumer Bank

Head Office

Barclays Group

Loan loss rate

£m

Credit impairment (charges)/ releases

(339)

(36)

(283)

(1,090)

(6)

(1,744)

£bn

Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)

230.9

29.2

15.2

129.8

29.8

2.6

437.5

Loan loss rate (bps)

(9)

489

n/m

Barclays Group

Loan loss rate

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Credit impairment charges

(503)

(571)

(823)

(535)

(632)

(469)

(643)

(711)

£bn

Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)

459.8

450.4

449.9

441.3

437.5

428.4

430.4

429.6

Loan loss rate (bps)

Barclays UK

Loan loss rate

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Credit impairment charges

(123)

(160)

(178)

(74)

(102)

(79)

(158)

(283)

£bn

Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)

243.3

239.8

233.6

231.9

230.9

228.5

227.5

Loan loss rate (bps)

Barclays UK Corporate Bank

Loan loss rate

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Credit impairment charges

(2)

(16)

(3)

(1)

(5)

(12)

(19)

(40)

£bn

Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)

33.2

31.4

31.0

30.2

29.2

28.2

27.0

25.8

Loan loss rate (bps)

Barclays Private Bank and Wealth Management

Loan loss rate

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Credit impairment (charges)/releases

(5)

(2)

(1)

(2)

£bn

Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)

16.4

15.1

15.2

14.8

14.7

Loan loss rate (bps)

(6)

(5)

(25)

Barclays Investment Bank

Loan loss rate

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Credit impairment charges

(33)

(44)

(279)

(22)

(144)

(67)

(72)

(46)

£bn

Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)

139.6

137.2

137.4

131.0

129.8

126.8

129.6

124.9

Loan loss rate (bps)

Barclays US Consumer Bank

Loan loss rate

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Credit impairment charges

(340)

(346)

(367)

(431)

(379)

(312)

(399)

(298)

£bn

Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)

25.5

25.0

30.3

30.6

29.8

27.4

28.9

30.0

Loan loss rate (bps)

529

555

491

558

505

456

562

395

Income over average RWAs

Barclays Investment Bank

Nine months ended 30.09.26

Nine months ended 30.09.25

£m

Income

11,115

10,263

£bn

Average RWAs

204.3

197.5

Income over average RWAs

7.3%

6.9%

Barclays Investment Bank

Q326

Q226

Q126

Q425

Q325

Q225

Q125

Q424

£m

Income

3,129

3,958

4,028

2,792

3,083

3,307

3,873

2,607

£bn

Average RWAs

206.3

204.5

202.0

202.1

194.9

196.1

201.4

199.9

Income over average RWAs

6.1%

7.7%

8.0%

5.5%

6.3%

6.7%

7.7%

5.2%

Tangible net asset value per share

As at 30.09.26

As at 31.12.25

As at 30.09.25

£m

Total equity excluding non-controlling interests

77,100

77,784

76,394

Other equity instruments

(13,275)

(12,725)

(13,243)

Goodwill and intangibles

(8,994)

(8,284)

(8,255)

Tangible shareholders' equity attributable to ordinary shareholders of the parent

54,831

56,775

54,896

Shares in issue

13,379

13,867

13,996

Tangible net asset value per share

410

409

392

Shareholder Information

Results timetable

Date

2026 Full Year Results and Annual Report

9 February 2027

% Change

Exchange rates

30.09.26

31.12.25

30.09.25

31.12.25

30.09.25

Period end - GBP/USD

1.33

1.34

(1)

YTD average - GBP/USD

1.34

1.32

1.31

3 month average - GBP/USD

1.34

1.33

1.35

(1)

Period end - GBP/EUR

1.17

1.15

YTD average - GBP/EUR

1.16

1.17

1.18

(1)

(2)

3 month average - GBP/EUR

1.17

1.14

1.15

Share price data

Barclays PLC (p)

458

476

380

Barclays PLC number of shares (m)

13,379

13,867

13,996

For further information please contact

Investor relations

Media relations

Marina Shchukina +44 (0) 20 7116 2526

Tom Hoskin +44 (0) 20 7116 4755

More information on Barclays can be found on our website:

home.barclays

Registered office

1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.

Registrar

Equiniti, Highdown House, Yeoman Way, Worthing, West Sussex, BN99 6DA, United Kingdom.

Tel +44 (0)371 384 2055 (UK and International telephone number)

American Depositary Receipts (ADRs)

Computershare Shareowner Services, P.O. Box 43304, Providence, RI 02940-3304, United States of America

General Toll Free: +1-866-723-8257

General Direct: +1-781-575-2833

www.computershare.com/investor

Delivery of ADR certificates and overnight mail

Computershare Shareowner Services, 150 Royall Street, Suite 101, Canton, MA 02021-1054

Note that this date is provisional and subject to change.

The change is the impact to GBP reported information.

The number of shares of 13,379m as at 30 September 2026 is different from the 13,372m quoted in the 1 October 2026 announcement entitled "Total Voting Rights" because the share buyback transactions executed on 29 and 30 September 2026 did not settle for cancellation until 1 and 2 October 2026 respectively.

Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact

[email protected]

or visit

www.rns.com

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our

END

QRTUAOBRNBURUAA

Source: the issuer's announcement on the London Stock Exchange's Regulatory News Service, reproduced for reference. Announcement text is the issuer's; this site adds no commentary to it.